Author: Manu Mengi

Dr. Manu Mengi is a best orthopedic doctor in Mohali, specializing in joint pain, arthritis, and sports injuries. With qualifications in orthopedics and advanced training in joint replacement, he provides effective care for bone and joint conditions, helping patients improve mobility and manage pain with the right treatment approach.

Why Young Adults Get Osteonecrosis: Warning Signs You Can’t Ignore

Osteonecrosis in young adults is surprisingly common, with studies showing that 60% of patients are below 40 years of age. This serious bone condition, also known as avascular necrosis (AVN), occurs when blood supply to the bones diminishes, most frequently affecting joints—especially the femoral head. Men are particularly vulnerable, with a roughly 4:1 ratio compared to women, and a striking 77% of cases showing male dominance.

In fact, the impact on young lives can be devastating. While many believe bone diseases only affect older populations, the data tells a different story. For children and young adults aged 1-25, incidence rates range from 1-17.6%, with those aged 10-25 facing even higher risks—up to 61.1%. Furthermore, early warning signs like persistent joint pain, stiffness, and difficulty walking often go unrecognized until significant damage has occurred.

Throughout this article, we’ll explore why young adults develop osteonecrosis, how to identify the warning signs you shouldn’t ignore, and what treatment options exist. Understanding this condition is crucial because early intervention can significantly improve outcomes—especially considering that approximately 90% of patients achieve good functional results after appropriate treatment.

What is Osteonecrosis and Why It Matters for Young Adults

Bone death sounds alarming – and it is. Osteonecrosis, derived from the Latin words “ossis” (bone) and “necrosis” (killing or causing to die), literally means “bone death”. Also known as avascular necrosis (AVN), aseptic necrosis, or ischemic bone necrosis, this condition occurs when blood supply to a bone is interrupted or reduced.

Definition and affected joints

At its core, osteonecrosis is a degenerative bone condition characterized by the death of cellular components of bone secondary to an interruption of the subchondral blood supply. This disruption can lead to tiny breaks in the bone and eventually cause bone collapse. The process typically takes months to years and most commonly affects the ends (epiphysis) of long bones.

The hip (femoral head) stands as the most frequent site for osteonecrosis, followed by the knee and shoulder. Other affected areas include:

  • The upper arm bone (humeral head)
  • The ankle
  • The wrist
  • The foot

Moreover, osteonecrosis often affects the weight-bearing joints. In approximately 20% of cases, if one bone develops nontraumatic osteonecrosis, the same bone on the opposite side may also be affected, even without symptoms. For instance, if one hip has osteonecrosis, about 60% of the time the other hip is similarly affected.

Why young adults are increasingly at risk

Initially, many believe bone diseases primarily affect older populations. Nevertheless, osteonecrosis primarily strikes people between 30 and 50 years of age, making it a significant concern for young adults. Each year, an estimated 10,000 to 20,000 people develop osteonecrosis in the United States alone.

The risk factors specifically relevant to young adults include:

  1. Steroid use: High-dose corticosteroids (like prednisone) represent a common cause of osteonecrosis. For younger patients, this often relates to treatment for conditions like acute lymphoblastic leukemia, where studies show osteonecrosis developing in 2.5% of patients.
  2. Alcohol consumption: Chronic, excessive alcohol use (more than 13 ounces weekly for over 6 months) is a major risk factor. This can cause fatty deposits to form in blood vessels, reducing blood flow to bones.
  3. Trauma: Injuries such as dislocated joints or fractures can damage nearby blood vessels. Specifically, osteonecrosis occurs in 15% to 80% of patients with femoral neck fractures.
  4. Blood disorders: Conditions like sickle cell anemia and lupus can diminish vascular supply to bone. In patients with acute leukemia, studies indicate symptomatic osteonecrosis developing within a median of 1.8 years after diagnosis.

For this reason, osteonecrosis matters tremendously for young adults. The long-term implications are profound – joint collapse, premature osteoarthritis, persistent pain, and potential disability[20]. Additionally, since most hip replacements have a finite lifespan, young patients may face revision surgeries throughout their lifetime.

The unique susceptibility of adolescents and young adults isn’t easily explainable. One hypothesis suggests steroid therapy induces proliferation of marrow lipocytes. In adolescents with epiphyseal closure, this fat-cell hypertrophy results in elevated intraosseous pressure, reduced intramedullary blood flow, marrow ischemia, and ultimately, necrosis.

In view of these factors, early recognition and intervention become crucial for young adults. Without treatment, osteonecrosis typically leads to progressive deformity of affected joints, declining function, disability, pain, and premature osteoarthritis.

Common Causes of Osteonecrosis in Young Adults

Understanding what causes osteonecrosis can help young adults identify their risk factors early. Research indicates that in non-traumatic cases, alcohol abuse and corticosteroid use account for up to 80% of occurrences. Let’s examine the primary causes affecting young adults.

Steroid induced Osteonecrosis in young adults

Steroid use represents the most frequent non-traumatic cause of osteonecrosis. Between 9% and 40% of patients receiving corticosteroid treatment eventually develop this condition. The risk increases dramatically with long-term therapy, particularly with daily doses exceeding 15-20 mg.

The exact mechanism remains debated, albeit well-documented. Glucocorticoids directly affect bone cells by:

  • Suppressing osteoblast precursor production
  • Increasing apoptosis of osteoblasts and osteocytes
  • Prolonging the lifespan of osteoclasts

Notably, certain patient populations face higher risks. Those with systemic lupus erythematosus, organ transplants, hematological diseases, multiple sclerosis, and SARS-CoV-2 infections show increased susceptibility. During the SARS epidemic of 2003, more than 1 in 5 patients developed osteonecrosis.

Even inhaled corticosteroids pose risks. Fluticasone propionate, commonly prescribed for chronic asthma, exhibits greater dose-related systemic effects than other inhaled steroids, particularly at doses exceeding 0.8 mg/day.

Alcohol related Osteonecrosis in young adults

Alcohol consumption represents another major risk factor, contributing to approximately 20-45% of osteonecrosis cases. The incidence in regular drinkers reaches as high as 5.3%.

Consequently, alcohol-induced osteonecrosis (AONFH) accounts for 32.4-45.3% of non-traumatic cases in Asia. The condition primarily affects men, with the male patient population roughly twice as large as the female population.

Alcohol damages bone through several mechanisms:

  • Causing fat cell hypertrophy and proliferation
  • Altering serum lipid levels
  • Occluding blood vessels
  • Increasing intraosseous pressure

These changes ultimately lead to inadequate blood supply and subsequent bone death. Furthermore, continued alcohol exposure worsens treatment outcomes, with 5-year survival rates after core decompression being lowest for alcohol-associated cases (22.1% versus 44.1% in idiopathic cases).

Traumatic Osteonecrosis in young adults

Trauma remains the most common overall cause of osteonecrosis. Femoral neck fractures or hip dislocations frequently disrupt blood flow to the femoral head. Accordingly, osteonecrosis occurs in 15-50% of femoral neck fractures and 10-25% of hip dislocations.

During these injuries, blood vessels supplying the femoral head become damaged, leading to interrupted circulation and eventual bone death. Unlike non-traumatic causes, the mechanism here is straightforward—direct physical damage to the vascular supply.

Non Traumatic Osteonecrosis in young adults

Beyond steroids and alcohol, several other non-traumatic factors can trigger osteonecrosis:

  • Blood disorders: Sickle cell disease causes misshapen red blood cells that impede blood flow, making the femoral head particularly vulnerable.
  • Autoimmune conditions: Systemic lupus erythematosus and other inflammatory disorders increase risk, sometimes regardless of steroid use.
  • Coagulation abnormalities: Thrombophilia is a significant risk factor, with Factor V Leiden mutations present in approximately 10% of patients.
  • Radiation therapy: About 20% of cases occur after radiation, though this has decreased to around 3% with optimized techniques.

Idiopathic Osteonecrosis in young adults

Despite extensive research, approximately 17-27% of osteonecrosis cases have no identifiable cause. These idiopathic cases present a challenge for both prevention and treatment.

Some researchers suggest genetic factors and gene polymorphisms may play roles in these unexplained cases. Regardless of the unknown cause, idiopathic cases show better outcomes than alcohol-related ones, with 5-year survival rates after core decompression at 44.1% compared to 22.1% for alcohol-associated cases.

Early Warning Signs You Shouldn’t Ignore

Recognizing the early signs of osteonecrosis can mean the difference between successful treatment and permanent disability. Given that osteonecrosis often progresses silently before causing noticeable symptoms, understanding these warning signals becomes essential, especially for young adults who might dismiss early discomfort as temporary or exercise-related.

Persistent joint pain or discomfort

The earliest and most common symptom of osteonecrosis is pain—often described as dull, throbbing, or aching. Typically, this discomfort begins gradually but becomes more intense over time. The pattern of pain offers important clues:

  • Location-specific pain: Most commonly felt in the groin, thigh, or buttock when the hip is affected
  • Activity-dependent pain: Initially present only during weight-bearing activities
  • Progressive nature: Pain that steadily worsens, eventually occurring even at rest or at night

What makes this warning sign particularly tricky is that many young adults attribute this pain to overexertion or minor injuries. However, a key differentiating factor is persistence—pain that continues beyond a few weeks warrants medical attention, primarily if it follows any risk factors mentioned in previous sections.

Joint stiffness in young adults

As blood supply diminishes and bone tissue begins to die, stiffness emerges as a telltale indicator. This stiffness differs from ordinary morning stiffness or post-exercise tightness in several ways:

  • It tends to be more pronounced after periods of inactivity
  • Unlike muscle stiffness, it doesn’t typically improve with gentle movement
  • The affected joint feels “locked” or resistant to normal range of motion

For young adults, joint stiffness might be easy to overlook or attribute to athletic activities. Yet persistent stiffness that limits everyday movements—such as difficulty putting on socks or shoes when hip osteonecrosis is present—should never be ignored.

Difficulty in walking in Osteonecrosis in young adults

As the condition progresses, walking becomes increasingly challenging. Obviously, this symptom varies depending on which joint is affected, but hip osteonecrosis (the most common type) creates distinctive walking difficulties:

  • Altered gait: A noticeable limp or uneven walking pattern
  • Weight-bearing limitations: Discomfort when putting weight on the affected side
  • Need for support: Gradually increasing reliance on canes, crutches, or other walking aids

First thing to remember is that these walking difficulties often develop subtly. A young adult might first notice slight discomfort when climbing stairs, then find themselves avoiding longer walks, and finally experience difficulty with basic mobility. This progression rarely happens overnight but instead unfolds over weeks or months.

Reduced range of motion

The final warning sign—and one that strongly indicates advancing disease—is decreased joint mobility. This restriction happens as the joint surface becomes damaged and irregular due to bone death and collapse.

Reduced range of motion manifests in different ways depending on the affected joint:

  • Hip: Difficulty or inability to rotate the hip inward or outward
  • Shoulder: Limited ability to raise the arm overhead or reach behind the back
  • Knee: Restricted bending or straightening capabilities

Essentially, this limitation often begins subtly—perhaps just a slight reduction in flexibility—but gradually becomes more pronounced and restrictive. Most importantly, unlike temporary stiffness that improves with stretching, the range-of-motion limitations in osteonecrosis tend to worsen over time rather than improve.

The key takeaway regarding these warning signs is their progressive nature. While individual symptoms might seem minor at first, their persistence and gradual worsening represent crucial red flags. Young adults experiencing any combination of these symptoms, particularly after exposure to known risk factors, should seek prompt medical evaluation rather than waiting until symptoms become severe or debilitating.

How Osteonecrosis is Diagnosed in Young Adults

Early diagnosis of osteonecrosis is crucial for preventing permanent joint damage in young adults. Currently, various diagnostic tools help clinicians identify this condition at different stages, with each offering specific advantages depending on when a patient seeks medical attention.

Physical examination and symptom history

The diagnostic journey typically begins with a thorough physical examination and comprehensive medical history. Although osteonecrosis may be asymptomatic in its early stages, making initial diagnosis challenging, a careful assessment can reveal important clues. Physicians should consider osteonecrosis primarily in younger patients presenting with joint pain who have known risk factors.

During the physical examination, doctors will assess:

  • Range of motion limitations in the affected joint
  • Pain with movement or weight-bearing
  • Changes in gait or mobility
  • Signs of joint swelling or tenderness

A focused medical history should explore potential risk factors, including:

  • Recent steroid exposure
  • Alcohol consumption patterns
  • Previous trauma to the area
  • Autoimmune conditions
  • Blood disorders like sickle cell disease
  • Recent orthopedic procedures

Screening of other joints is equally important, as osteonecrosis can affect multiple sites simultaneously. The risk of developing osteonecrosis in the contralateral hip when one side is affected ranges from 31% to 55%. In addition to the femoral head, osteonecrosis commonly affects the humeral head, femoral condyles, proximal tibiae, wrists, ankles, and bones of hands and feet.

X-Ray detection of Osteonecrosis in young adults

Plain radiographs (X-rays) are often the initial imaging tool used when evaluating suspected osteonecrosis. Although X-rays provide a readily accessible and inexpensive starting point, they have significant limitations for early-stage detection.

In the early phases, X-rays may show only minor osteopenia compared to the contralateral bone. As the disease progresses, characteristic findings emerge:

  • Patchy areas of lucency with serpentine rims of sclerosis
  • Sclerotic changes in small bones compared to adjacent structures
  • The “crescent sign” – a linear crescentic subchondral lucency indicating imminent articular collapse

While helpful for excluding other causes of bone pain, standard radiographs generally confirm diagnosis only in more advanced stages of osteonecrosis. Furthermore, they frequently appear normal early in the disease course, potentially delaying proper treatment.

MRI for early detection of Osteonecrosis in young adults

Magnetic Resonance Imaging (MRI) stands as the gold standard for diagnosing osteonecrosis, with nearly 100% sensitivity and specificity for early detection. In contrast to X-rays and other imaging modalities, MRI can detect bone ischemia and osteonecrosis at an early stage, even when the patient remains asymptomatic.

The classic MRI findings in osteonecrosis include:

  • Well-circumscribed geographic areas with distinct signal patterns
  • Margins of low signal on T1-weighted and high signal on T2-weighted images (viable tissue)
  • Alternatively, low signal on both T1 and T2-weighted images (necrotic tissue)

Most distinctively, the “double-line sign” serves as a diagnostic hallmark – an outer low signal and inner high signal circumscribing the affected area on T2-weighted sequences. This sign represents the outside rim of sclerosis and the reactive interface or “zone of creeping substitution”.

Beyond these established criteria, research has identified even earlier MRI signs that precede typical findings – subtle signal changes appearing as thin indistinct winding lines of T1 hypointensity with corresponding T2 STIR hyperintensity. These changes help predict subsequent development of extensive osteonecrosis on follow-up examinations.

At some institutions, all patients with acute lymphoblastic leukemia and bone marrow transplant recipients undergo MRI screening for early detection of osteonecrosis, regardless of symptoms. This proactive approach highlights the value of early identification, as MRI can detect changes as early as one week after vascular injury.

The presence of bone marrow edema on MRI is particularly significant, as it predicts worsening pain and future disease progression. Although MRI remains the optimal test for early diagnosis, its widespread use faces constraints due to higher economic costs and various contraindications. For this reason, physicians must carefully consider which patients warrant this advanced imaging based on risk factors and clinical presentation.

Stages of Osteonecrosis and What They Mean

Understanding the stages of osteonecrosis helps predict outcomes and guide treatment decisions for young adults. Regardless of which joint is affected, the disease follows a predictable pattern of progression that can be classified into distinct stages using various systems.

Stage 0 to Stage 4 overview

Several classification systems exist for staging osteonecrosis, with the Ficat and Arlet classification being one of the most widely used. This system combines clinical symptoms, radiographic findings, and MRI results to categorize the severity of bone damage:

Stage 0: This preclinical, silent stage shows normal imaging on both radiographs and MRI but may present abnormalities in bone marrow pressure and histology studies. Though asymptomatic, this stage can be detected if osteonecrosis has already been diagnosed in the contralateral joint.

Stage I: At this point, radiographs typically appear normal or show minor osteopenia. However, MRI reveals bone marrow edema, and patients often experience pain—typically in the groin for hip osteonecrosis. Bone scans at this stage show increased uptake, confirming the beginning of the disease process.

Stage II: As the condition advances, radiographs begin to show mixed osteopenia, sclerosis, and/or subchondral cysts, without any subchondral lucency. MRI displays a characteristic geographic defect. Clinically, patients experience increasing pain and joint stiffness.

Stage III: This critical stage marks the beginning of structural failure. Radiographs and MRI reveal the pathognomonic “crescent sign” indicating subchondral collapse. Subsequently, the femoral head (or other affected joint surface) begins to flatten. Pain intensifies, now radiating to surrounding areas like the knee in hip osteonecrosis, and patients develop a noticeable limp.

Stage IV: The final stage shows advanced degenerative changes on imaging. The joint space narrows significantly, and secondary changes appear in adjacent joint surfaces. Throughout this stage, pain becomes constant and mobility severely limited.

Some classification systems add additional stages. The Steinberg system, for instance, expands Ficat’s four stages into six stages and incorporates quantification of involvement within each stage—mild (less than 15% of articular surface), moderate (15-30%), or severe (greater than 30%).

Progression from silent to severe stages

The timeline of progression through these stages varies significantly among patients. Contrary to osteoarthritis, which typically develops slowly over many years, osteonecrosis often advances relatively quickly—within 12-18 months or sometimes over just a few months.

Initially, the disease begins silently. Young adults with stage 0 osteonecrosis experience no symptoms whatsoever. Henceforth, the condition evolves with subtle changes detectable only on MRI before progressing to produce noticeable symptoms.

Hip pain typically emerges as the first indicator. This discomfort usually presents as a dull ache or throbbing pain in the groin or buttock area. As bone deterioration continues, standing and weight-bearing become increasingly difficult, and joint movement causes significant pain.

The progression from stage I to stage IV creates a predictable pattern of disability:

  • Early stages (0-I): Minimal or no symptoms, normal radiographs
  • Middle stages (II): Increasing pain, visible changes on radiographs
  • Advanced stages (III-IV): Joint collapse, significant pain, and functional limitations

Core decompression surgery demonstrates the best results when performed during early stages, before bone collapse occurs. In these cases, the bone can potentially heal and regain its blood supply. Straightaway after successful procedures, patients typically return to walking unassisted within approximately 3 months.

If diagnosed after collapse (stage III or beyond), core decompression generally proves unsuccessful in preventing further deterioration. At this point, total joint replacement often becomes the most viable option for relieving pain and restoring function.

Treatment Options: From Conservative to Surgical

Treatment decision-making for osteonecrosis hinges on timing and disease stage. Managing this condition effectively requires a stage-appropriate approach that balances joint preservation with long-term outcomes.

Conservative treatment Osteonecrosis in young adults

Non-surgical approaches serve as first-line interventions for early-stage osteonecrosis. These typically include:

  • Restricted weight-bearing using canes, crutches, or walkers to delay disease progression, though evidence suggests reducing joint forces alone may not significantly slow advancement
  • Pharmacological interventions such as bisphosphonates, statins, vasodilators, and anticoagulants target biological pathways involved in osteonecrosis
  • Extracorporeal shockwave therapy (ESWT) stimulates osteoblastic activity, increasing bone density with most significant benefits seen in early disease stages
  • Hyperbaric oxygen therapy (HBOT) enhances tissue oxygen partial pressures, stimulating osteoblasts and reducing inflammation, with protocols typically involving 60-90 daily sessions

Certainly, conservative approaches work best before femoral head collapse occurs. As a stand-alone strategy, non-surgical management generally serves as an interim solution rather than definitive treatment for most young patients.

Core decompression surgery in young adults

Core decompression remains the most widely performed joint-preserving procedure, creating channels within necrotic bone to relieve pressure and promote revascularization. This procedure shows optimal results when performed before femoral head collapse, with success rates varying from 34-95%.

The efficacy of core decompression correlates directly with disease stage. Patients with Ficat stage I disease demonstrate significantly better outcomes with approximately 80% success rates compared to those with stage III disease. Moreover, lesion size and location influence results—lateral or central lesions show higher failure rates than medial ones.

Recent technical improvements include multiple small-diameter drilling rather than single large core removal, reducing complications like subtrochanteric fractures. This modified approach has shown comparable efficacy with traditional methods while minimizing invasiveness.

Hip Replacement surgery in young adults

Once femoral head collapse occurs, total hip arthroplasty (THA) often becomes necessary. Presently, advances in implants and revision techniques have made THA viable even as initial treatment for young osteonecrosis patients.

Long-term studies show promising results—implant survival rates of 100% at 60 months, 98% at 120 months, and 94% at 180 months. Remarkably, when considering aseptic loosening as the endpoint, the 180-month survival rate reaches 100%.

Despite concerns about revision surgeries in young patients, modern implants demonstrate excellent durability. Correspondingly, clinical outcomes show high functionality, with median Japanese Orthopedic Association scores of 100 points at final follow-up.

Stem cell therapy for Osteonecrosis in young adults

Stem cell therapy, particularly using mesenchymal stem cells (MSCs), represents a breakthrough in biological treatment aimed at restoring bone structure and vascularity. This approach has emerged as a promising joint-preservation strategy for young adults.

Studies show that autologous cell therapy combined with core decompression significantly reduces femoral head collapse risk (odds ratio = 0.2) compared to decompression alone. Investigations demonstrate that stem cell therapy delivers superior clinical and radiological outcomes, especially in precollapse stages.

In long-term follow-up studies spanning up to 15 years, patients treated with bone marrow concentrate showed better survival time before revision than those receiving primary total hip arthroplasty. Furthermore, complications from stem cell procedures appear infrequent and primarily related to bone marrow aspiration.

Rehabilitation and Recovery After Treatment

After receiving treatment for osteonecrosis, young adults face another crucial phase – rehabilitation. The recovery process plays a vital role in determining long-term outcomes and quality of life. Let’s explore the key components of successful rehabilitation.

Physical therapy and mobility training

Physical therapy forms the cornerstone of rehabilitation for young osteonecrosis patients. Healthcare professionals typically recommend several approaches:

  • Rest and weight restriction: Limiting weight-bearing activities or using crutches for several months helps slow bone damage progression. This reduced load gives the bone a chance to heal.
  • Range-of-motion exercises: A physical therapist can teach specific movements to maintain or improve joint mobility. These exercises typically begin with passive movements and stretching before advancing to more active techniques.
  • Progressive strengthening: As joint contractures improve, therapy shifts toward muscle-strengthening and endurance training. This step-by-step approach prevents overwhelming the healing joint while rebuilding necessary support.
  • Gait training: Proper walking mechanics become crucial once weight-bearing is allowed. If limping persists, continued use of walking aids like canes may be recommended.

For hip osteonecrosis specifically, therapy focuses on the surrounding muscles – not just the joint itself. Strengthening exercises target hip, thigh, back, and core muscles that provide essential joint support.

Pain management strategies

Managing pain effectively enables better participation in rehabilitation activities. Several approaches work together:

Firstly, modalities like thermotherapy (heat) often provide significant relief for deep joint pain. Meanwhile, electrical stimulation represents another valuable option, working through two mechanisms: encouraging new bone growth and directly reducing pain.

In many cases, analgesic medications help control discomfort during early rehabilitation phases. Nevertheless, successful comprehensive rehabilitation can eventually eliminate the need for pain medication. Indeed, one case study documented complete discontinuation of tramadol after just 20 days of rehabilitation treatment.

Can young adults recover from Osteonecrosis in young adults?

Recovery prospects for young adults with osteonecrosis depend largely on early intervention, treatment approach, and rehabilitation compliance. Thus, physical therapy can be quite effective if osteonecrosis is detected early – though treatment aims to prevent further damage rather than reverse existing damage.

The recovery timeline varies based on treatment type. Following core decompression, patients typically return to unassisted walking within approximately 3 months. Afterward, progressive rehabilitation continues with gradually increasing intensity.

Success stories demonstrate remarkable potential for recovery. For instance, one documented case showed a young patient who, after comprehensive rehabilitation, experienced pain reduction from severe to minimal levels (NRS score of 1) without medications. Two years post-treatment, this individual had returned to work, married, had a child, and was leading an active social life.

The key to successful recovery lies in a multidisciplinary approach focused not just on eliminating pain but on empowering patients to better manage their condition through environmental adjustments and enhanced self-efficacy.

Prevention and Lifestyle Changes That Help

Preventing osteonecrosis starts with identifying modifiable risk factors that contribute to bone damage. Taking action early can protect young adults from this debilitating condition.

Quitting alcohol to prevent Osteonecrosis in young adults

As a matter of fact, alcohol abuse accounts for approximately 20-45% of osteonecrosis cases. The incidence in regular drinkers reaches as high as 5.3%. Even worse, continued alcohol exposure leads to inferior treatment outcomes, with 5-year survival rates after core decompression being merely 22.1% versus 44.1% in idiopathic cases. To minimize risk, experts recommend limiting alcohol consumption to one drink daily for women and two drinks daily for men.

Avoiding steroids in bone damage

In the long run, steroid use increases osteonecrosis risk by up to 20 times. Between 9% and 40% of patients receiving corticosteroid treatment eventually develop this condition. Under those circumstances, the most compelling evidence suggests tapering corticosteroids to the lowest necessary dose. If prescribed steroids, work closely with your healthcare provider to avoid long-term use whenever possible.

Monitoring bone health proactively

To be sure, maintaining strong bones requires a comprehensive approach. Consume a diet rich in calcium from dairy, nuts, and green vegetables. Vitamin D, either from sun exposure or supplements, remains equally crucial. Weight-bearing exercises like walking, dancing, or hiking help strengthen bones. Regular bone density testing may be recommended if you’re over 50 or have risk factors for bone loss.

Conclusion

Osteonecrosis represents a serious threat to young adults, though many still mistakenly view it as an older person’s condition. Throughout this article, we’ve seen how this bone death process disproportionately affects those under 40, particularly men. Early recognition of warning signs such as persistent joint pain, stiffness, and mobility limitations can significantly alter the disease trajectory.

Undoubtedly, the best outcomes occur when diagnosis happens before bone collapse. MRI technology now allows detection at the earliest stages, sometimes even before symptoms appear. This early identification means young patients can benefit from less invasive interventions like core decompression or emerging stem cell therapies rather than facing joint replacement surgery.

The stark reality remains that certain lifestyle factors dramatically increase risk. Alcohol consumption and steroid use stand as the two most significant modifiable risk factors, together accounting for up to 80% of non-traumatic cases. Young adults must therefore consider these connections when making health decisions.

Prevention strategies should focus on bone health maintenance through proper nutrition and weight-bearing exercise. Those already diagnosed must commit to comprehensive rehabilitation programs that strengthen surrounding muscles and restore proper movement patterns. Physical therapy, while challenging, offers the best path toward functional recovery.

Life after osteonecrosis diagnosis does not mean permanent disability for young adults. Modern treatment approaches combined with dedicated rehabilitation now provide much better outcomes than ever before. The key lies in awareness, early action, and appropriate treatment selection based on disease stage. Young adults experiencing unexplained joint pain should never dismiss their symptoms but instead seek prompt medical evaluation – because when it comes to osteonecrosis, time truly matters.

Key Takeaways

Osteonecrosis isn’t just an older person’s disease—it primarily affects young adults under 40, with early detection and intervention being crucial for preventing permanent joint damage and disability.

• Recognize the warning signs early: Persistent joint pain, stiffness, walking difficulties, and reduced range of motion are red flags that shouldn’t be dismissed as exercise-related discomfort.

• Address modifiable risk factors immediately: Alcohol abuse and steroid use account for 80% of cases—limiting alcohol and avoiding long-term steroids significantly reduces your risk.

• Seek MRI diagnosis before X-rays show damage: MRI can detect osteonecrosis weeks before symptoms appear, while X-rays only show advanced stages when treatment options become limited.

• Treatment success depends on timing: Core decompression and stem cell therapy show 80% success rates in early stages, but joint replacement becomes necessary once bone collapse occurs.

• Recovery requires comprehensive rehabilitation: Physical therapy, pain management, and lifestyle modifications enable young adults to return to active lives and prevent further joint deterioration.

The bottom line: Don’t ignore persistent joint pain if you have risk factors. Early intervention can mean the difference between preserving your natural joint and needing replacement surgery in your twenties or thirties.

FAQs

Q1. What are the early warning signs of osteonecrosis in young adults? Early signs include persistent joint pain, especially in the hip or knee, that worsens with weight-bearing activities. Other symptoms are joint stiffness, difficulty walking, and reduced range of motion. These symptoms often develop gradually over weeks or months.

Q2. What are the main causes of osteonecrosis in young people? The most common causes in young adults are excessive alcohol consumption and long-term use of high-dose corticosteroids. Traumatic injuries, blood disorders like sickle cell disease, and certain autoimmune conditions can also lead to osteonecrosis. In some cases, the cause remains unknown (idiopathic).

Q3. How is osteonecrosis diagnosed in its early stages? MRI is the gold standard for early diagnosis of osteonecrosis, capable of detecting changes even before symptoms appear. X-rays are often normal in early stages. A thorough physical examination and medical history, focusing on risk factors, are also crucial in the diagnostic process.

Q4. What treatment options are available for young adults with osteonecrosis? Treatment depends on the disease stage. Early-stage options include conservative measures like restricted weight-bearing and medications. Core decompression surgery and stem cell therapy show promise in preserving the joint. In advanced stages with bone collapse, joint replacement may be necessary.

Q5. Can lifestyle changes help prevent osteonecrosis in young adults? Yes, certain lifestyle changes can significantly reduce the risk. Limiting alcohol consumption, avoiding long-term use of high-dose steroids when possible, maintaining a healthy diet rich in calcium and vitamin D, and engaging in regular weight-bearing exercises can all contribute to better bone health and lower osteonecrosis risk.

December 9, 2025 / by Manu Mengi

Post – Covid-19 Musculo – Skeletal Disorders

Post-COVID-19 Musculo-Skeletal Disorders affect millions of people worldwide since the pandemic began, causing significant health challenges beyond respiratory symptoms. The pandemic has negatively affected healthcare systems and caused both economic and social burden almost all over the world, with more than 6 million deaths recorded.

When we look at the data, musculoskeletal symptoms appear alarmingly frequent. In fact, studies show that fatigue affects up to 63% of COVID survivors, while muscle pain has a pooled prevalence of 28%. Additionally, joint pain affects 14.8% of patients even months after recovery. Many patients also report increased pain levels, with mean pain scores rising from 4.48 pre-COVID to 6.92 post-COVID. The most commonly affected areas include the lower back and shoulders. Although these symptoms might seem temporary, the prevalence of post/long COVID-19 syndrome ranges from 10% to 30%, indicating a significant long-term impact.

Throughout this article, we’ll explore how COVID-19 affects the musculoskeletal system, early symptoms to recognize, treatment options, and strategies for building an effective rehabilitation plan. Whether you’re currently experiencing these symptoms or helping someone who is, understanding these disorders is the first step toward effective management and recovery.

How COVID-19 Affects the Musculoskeletal System

Understanding the mechanisms by which COVID-19 disrupts our musculoskeletal system reveals a complex interplay of direct viral damage, inflammatory responses, and the consequences of reduced physical activity.

Direct viral effects on muscle and bone

The SARS-CoV-2 virus gains entry to human cells through angiotensin-converting enzyme 2 (ACE2) receptors and serum transmembrane protease 2 (TMPRSS2). Interestingly, these receptors are present not only in respiratory tissues but also in skeletal muscle and bone cells. This explains how the virus directly attacks musculoskeletal tissues.

Studies of muscle tissue collected from patients who died from SARS (a related coronavirus) revealed widespread muscle fiber atrophy with sporadic and focal muscle fiber necrosis. Under electron microscopy, researchers observed myofibril disarray and Z disk streaming, which significantly disrupts force transmission in muscles.

Beyond muscle damage, COVID-19 also affects bone health through direct viral action. Osteoclasts (cells that break down bone tissue) express ACE2 receptors, making them potential targets for the virus. Multiple animal studies have demonstrated dramatic bone loss following SARS-CoV-2 infection. For instance, mice infected with COVID-19 exhibited a 24.4% reduction in trabecular bone volume fraction in just two weeks, coupled with a 60% increase in osteoclast numbers. Notably, even asymptomatic mice displayed these significant changes, suggesting that immobility alone cannot explain the bone loss.

Immune response and inflammation

The inflammatory response to COVID-19 infection, particularly the “cytokine storm,” plays a crucial role in musculoskeletal damage. During this process, the body releases excessive amounts of proinflammatory cytokines that damage multiple organ systems, including muscles and bones.

Several inflammatory markers have been directly linked to musculoskeletal damage:

  • C-reactive protein (CRP) levels in severe COVID-19 cases are often several-fold higher than in healthy individuals, correlating with muscle damage
  • Interleukins (IL-1β, IL-6, IL-17) and tumor necrosis factor-alpha (TNF-α) directly induce muscle fiber breakdown while simultaneously decreasing protein synthesis
  • These same inflammatory molecules can block the proliferation and differentiation of satellite cells—progenitor cells essential for muscle repair and growth
  • IL-1β and IL-6 promote muscle fibrosis, impairing force production and increasing injury risk

Furthermore, the cytokine storm can lead to vascular damage in and around nerves and muscles. About 19% of hospitalized COVID-19 patients show elevated creatine kinase (CK) levels—a marker of muscle damage—with some cases reaching extremely high values (up to 12,216 U/L).

For bone health, inflammatory cytokines like CXCL10, IL-17, and TNF-α promote osteoclast activity while reducing osteoblast function (bone-forming cells), resulting in net bone loss.

Impact of prolonged inactivity

The COVID-19 pandemic forced many people into prolonged periods of inactivity due to lockdowns, hospitalization, or self-isolation. This lack of physical activity had profound negative effects on musculoskeletal health.

Physical inactivity is already highly prevalent in patients with rheumatic diseases (38-72%), but the pandemic exacerbated this problem for the general population. Even brief periods of reduced activity can be harmful—a two-week reduction in daily steps from approximately 10,000 to 1,500 steps leads to impaired insulin sensitivity, altered lipid metabolism, increased visceral fat, and decreased cardiovascular fitness in healthy adults.

For hospitalized COVID-19 patients, especially those requiring intensive care, the effects of immobility are even more severe. Bed rest, once considered beneficial for inflammatory conditions, is now known to accelerate joint destruction and muscle atrophy. Patients who recovered from SARS showed a 32% reduction in grip strength and a 13% decrease in six-minute walking distance 2-3 months after hospital discharge compared to healthy controls.

Moreover, during lockdown periods, people reported spending significantly more time watching television, using smartphones, and sleeping—all sedentary behaviors that correlate with increased musculoskeletal pain.

Recognizing the Symptoms Early

Identifying post-COVID musculoskeletal problems early allows for prompt intervention and better outcomes. As research continues to accumulate, distinct patterns of symptoms have emerged that can help both patients and healthcare providers recognize these conditions sooner rather than later.

Post-COVID fatigue and weakness

Physical fatigue stands out as the most prevalent long-term symptom following COVID-19 recovery, affecting more than 60% of individuals with long COVID. This isn’t ordinary tiredness—it’s often profound exhaustion that severely limits daily activities and can persist for months. Many patients describe a characteristic fluctuating pattern, where symptoms worsen unexpectedly after even minor physical exertion.

The underlying cause appears multifaceted. Research has revealed that COVID-19 can damage mitochondria (our cells’ power plants) and interfere with the electron transport chain that supplies energy to muscles. Subsequently, this leads to persistent weakness, reduced exercise tolerance, and rapid exhaustion. In more severe cases, patients demonstrate measurable declines in physical capacity—a study of recovered patients showed approximately a 32% reduction in grip strength and a 13% decrease in walking distance compared to healthy individuals.

Joint stiffness and pain

Joint pain (arthralgia) represents another hallmark of post-COVID musculoskeletal disorders, with prevalence rates ranging from 2% to 65% within the first year following infection. The knee, ankle, foot, and shoulders tend to be most frequently affected.

The pain experience varies considerably among individuals:

  • 49.4% describe moderate intensity pain
  • 26.1% report severe pain
  • 4.9% experience very severe pain

This discomfort follows recognizable patterns—many patients notice their symptoms worsen in the morning and evening hours but improve somewhat with gentle exercise. Beyond mere discomfort, joint pain significantly impacts quality of life, with 88.9% of COVID survivors with persistent muscle/joint pain reporting reduced life quality compared to those without such symptoms.

Muscle cramps and tenderness

Muscle pain (myalgia) affects between 25% to 61% of long COVID patients, typically concentrated in the back, shoulders, and neck regions. Unlike some symptoms that appear immediately, muscle issues can emerge gradually, sometimes taking up to three months to fully manifest.

Interestingly, muscle biopsies from individuals experiencing persistent fatigue 5-14 months after infection reveal telling abnormalities—38% show muscle fiber atrophy while 56% display evidence of ongoing fiber regeneration. Electromyography tests frequently detect myopathic changes, with 75% of tested patients showing abnormal results consistent with muscle damage.

The nature of this pain resembles rheumatic conditions, leading some researchers to theorize that COVID-19 triggers an inflammatory response that mimics arthritis. Additionally, direct viral damage to motor neurons and adjacent muscles can occur during acute infection, potentially explaining why weakness persists long after the virus has cleared.

Sleep disturbance and fatigue

Sleep problems represent a frequently overlooked yet critical component of post-COVID recovery. Studies report vastly different prevalence rates ranging from 6% to over 70%, though one comprehensive international survey found 78.58% of long COVID patients suffered from sleep disturbances.

These problems manifest in various ways—difficulty falling asleep (39% vs. 31% pre-COVID), trouble staying asleep (57% vs. 43% pre-COVID), and increased reliance on sleep aids (30% vs. 24% pre-COVID). Moreover, patients report feeling less rested upon waking and an increased need for daytime napping.

Concerningly, these sleep disruptions prove stubbornly persistent, with 28% of patients still experiencing symptoms beyond 12 months after infection. Given sleep’s crucial role in musculoskeletal recovery, these disturbances create a troubling cycle—poor sleep impairs healing, which causes pain, which further disrupts sleep.

The combined effect of these symptoms can be devastating, with multiple studies showing significant negative impacts on quality of life, work capacity, and social functioning.

The Role of Inflammation and Immune Dysregulation

Immune system dysregulation represents a fundamental driver of post-COVID musculoskeletal disorders, with inflammation playing a central role in both acute and chronic phases of the illness. Beyond the initial infection, these immune abnormalities can persist for months, creating a cascade of effects throughout the body’s connective tissues.

Cytokine storm and tissue damage

The term “cytokine storm” describes the excessive activation of immune cells and significant increase in circulating cytokines that characterizes severe COVID-19 cases. This overwhelming inflammatory response creates a vicious cycle as abundant inflammatory cytokines cause profound hyper-inflammation and mobilize immune cells.

Within damaged muscle tissue, this storm elevates cytolytic and cytotoxic molecules along with reactive oxygen species (ROS), which aggravates tissue injury—sometimes extending to healthy nearby tissues. Severe inflammation in skeletal muscles can progress to rhabdomyolysis, potentially causing sepsis-like systemic inflammatory response syndrome and remote organ damage.

The mechanics of this damage are intricate. After initial injury, both local and recruited immune cells activate at the injured site. These activated lymphocytes, macrophages, and neutrophils contain radical-forming enzymes in their intracellular granules that generate ROS, which further increases tissue injuries and enhances immune responses. Concurrently, pro-inflammatory cytokines released from activated phagocytes accelerate muscle protein degradation.

Should tissue damage become prolonged and repair fails, a protein called HMGB1 released by necrotic tissues and immune cells induces a second wave of inflammatory responses, establishing chronic inflammation. This continuous inflammation contributes to various inflammatory diseases, which in turn stimulate more damage-associated molecular patterns (DAMPs), creating an ongoing destructive cycle.

Persistent low-grade inflammation

Many long COVID patients demonstrate a condition called low-grade inflammation (LGI)—a chronic, ineffective inflammatory state that leads to oxidative stress and causes ongoing tissue damage. In fact, approximately two-thirds of long COVID patients have persistently high levels of certain inflammatory signals.

This persistent inflammation differs significantly from those who recovered fully from COVID-19. In individuals who recovered completely, inflammation levels initially increased during infection but subsequently normalized as they healed. However, in those with long COVID, these inflammatory levels never returned to baseline.

LGI manifests through common symptoms including chronic fatigue, arthralgia, myalgia, anxiety, depression, and digestive issues. The underlying biological mechanisms involve slight elevations of acute-phase reactants and cytokines. A meta-analysis of 23 studies evaluating 18 inflammatory biomarkers revealed that C-reactive protein (CRP), lactate dehydrogenase (LDH), D-dimer, and leucocytes remained elevated in long COVID patients compared with those who recovered fully.

Interestingly, fatigue—the most prevalent symptom of post-COVID syndrome—correlates directly with high levels of erythrocyte sedimentation rate (ESR), LDH, CRP, and D-dimer. This association may be explained by the production of reactive oxygen species by activated neutrophils, which causes oxidative tissue damage.

Autoimmune responses and flare-ups

Perhaps most concerning is COVID-19’s apparent ability to trigger autoimmune responses. Approximately 9.5% of COVID-19 survivors report developing autoimmune diseases post-infection, with systemic lupus erythematosus being most frequent (75% of autoimmune cases), followed by rheumatoid arthritis (19%) and autoimmune thyroiditis (6%).

Research demonstrates an alarming 42.6% increased risk of autoimmune diseases among chronic COVID patients. More specifically, studies have identified a 3.2-fold increased risk of ankylosing spondylitis, a 3.14-fold greater risk of mixed connective tissue disease, a 2.99-fold higher risk of lupus erythematosus, and a 2.98-fold increased risk of rheumatoid arthritis.

The molecular basis for this autoimmunity involves SARS-CoV-2’s multiple epitopes that cross-react with host antigens. For example, researchers have shown cross-reactivity between SARS-CoV-2 epitopes and those on heat shock proteins, which could contribute to autoimmune conditions. Remarkably, up to 45% of COVID-19 patients exhibit at least one circulating autoantibody, with higher concentrations often resulting in more severe symptoms.

When Medications Make It Worse

Medications prescribed during COVID-19 treatment can sometimes worsen musculoskeletal problems, creating a challenging paradox for both patients and healthcare providers. While certain drugs proved life-saving during acute infection, their lasting impact on muscle and bone health requires careful consideration.

Steroid-related muscle and bone loss

Corticosteroids emerged as cornerstone treatments during the pandemic, yet their musculoskeletal side effects can be significant. These medications, despite saving countless lives, come with substantial risks to bone and muscle integrity. The main adverse effects include myopathy, muscle atrophy, muscle weakness, and osteonecrosis.

Prolonged steroid use frequently leads to glucocorticoid-induced osteoporosis, which dramatically increases fracture risk. Beyond this, avascular necrosis (AVN) of the femoral head represents one of the most devastating complications. Even with the low-dose dexamethasone protocol from the RECOVERY trial (equivalent to approximately 400 mg of prednisone), patients remain vulnerable. Remarkably, some patients developed osteonecrosis with cumulative prednisone doses as low as 290-400 mg.

Risk factors for steroid-induced complications appear dose-dependent:

  • Each 10 mg increase in daily steroid dose correlates with approximately 3.6% higher rates of osteonecrosis
  • Risk increases 1.57 times per 5.0 g increase in cumulative steroid dose
  • Each additional 10 days of treatment duration increases osteonecrosis risk by 1.29 times

A proposed risk stratification system categorizes patients as low-risk (no steroids), moderate-risk (cumulative dose <2000 mg for <1 week), or high-risk (≥2000 mg for ≥1 week or IV pulse ≥80 mg/day for ≥3 days).

NSAIDs in musculoskeletal pain: pros and cons

Non-steroidal anti-inflammatory drugs remain widely used for managing COVID-19 symptoms like fever, body aches, and headaches. Early pandemic concerns about their safety have largely been resolved through extensive research.

According to current evidence, NSAIDs provide several benefits in COVID-19 management:

  • Affordable and readily available over-the-counter
  • Well-established benefit-risk profile
  • Essential for managing chronic inflammatory conditions

The overwhelming majority of 24 relevant publications showed that NSAIDs neither increase SARS-CoV-2 infection likelihood nor worsen clinical outcomes. Furthermore, a meta-analysis demonstrated no increased mortality risk among NSAID users versus non-users.

Nevertheless, certain precautions remain advisable. The European Union’s National Treatment Guidelines recommend patients with COVID-19 can continue NSAIDs, yet advise using the lowest effective dose for the shortest required time. This balanced approach recognizes both benefits and potential concerns without contradicting their overall safety profile.

Other drugs linked to muscle weakness

Several other medications commonly prescribed during COVID-19 have been associated with musculoskeletal complications. Hydroxychloroquine/chloroquine, initially used widely before later studies showed limited efficacy, can cause myopathy as a primary adverse effect. Similarly, azithromycin, often chosen for pulmonary infections, carries potential muscle weakness risks.

Concerning statins, research indicates COVID-19 infection may intensify typical statin-related side effects. A study of 66 COVID-19 patients found those using statins experienced more frequent and intense muscle pain compared to controls. Additionally, muscle weakness occurred more frequently in statin users, and creatine kinase levels were higher, often correlating with moderate to severe muscle pain.

Certain antiviral treatments also present musculoskeletal risks. Studies report that lopinavir/ritonavir can lead to musculoskeletal pain and fatigue, while both interferon α and β have been linked to arthralgia and myalgia in some patients.

Given these potential complications, medication management requires careful consideration of individual risk factors, especially in patients already experiencing post-COVID musculoskeletal symptoms.

Living with Long COVID Muscle Pain

Living with long COVID muscle pain transforms everyday activities into significant challenges. The persistent symptoms extend far beyond occasional discomfort, creating a new reality for those affected by Post-COVID-19 Musculo-Skeletal Disorders.

How it affects daily life and mobility

The impact of long COVID on daily functioning is profound. Approximately 72% of COVID-19 survivors report long-lasting clinical complications. Among the most debilitating are fatigue (47.9%), muscle and joint pain (35.5%), and shortness of breath (34.7%). Consequently, these symptoms severely restrict normal activities.

Studies reveal that 75.5% of affected individuals report problems performing daily activities. Even basic self-care becomes challenging, with 64% of patients experiencing functional impairment. Physical health scores drop significantly in those with persistent pain, creating a vicious cycle of decreased activity and worsening symptoms.

Many describe their condition as having “strange,” “energy-sapping,” and often fluctuating muscle weakness that dramatically limits mobility. At the most extreme, some patients become essentially bedridden, unable to participate in previously routine activities. This has substantial economic implications as many affected individuals cannot maintain their previous work capacity.

Exercise intolerance after COVID

Exercise intolerance—the inability to perform physical activity at previously normal levels—emerges as a hallmark feature of long COVID. This manifests as dramatically reduced exercise capacity, with patients showing significant decreases in the six-minute walking test (6MWT) distances compared to those without long COVID.

In one study, individuals with long COVID walked an average of only 448 meters in the 6MWT, whereas fully recovered individuals averaged 509 meters. This difference reflects serious physiological impairments rather than just deconditioning.

The mechanisms behind exercise intolerance are multifaceted:

  • Damaged mitochondria disrupting energy production in muscle cells
  • Impaired diffusion capacity limiting oxygen utilization
  • Persistent microthrombi in muscle capillaries reducing blood flow
  • Altered muscle fiber composition favoring easily fatigable fibers

Exercise often triggers what’s called post-exertional malaise—a worsening of symptoms after even modest exertion. This leads to “boom-bust” cycles where patients push themselves on good days, essentially resulting in relapses that further limit future activity.

Postural orthostatic tachycardia syndrome (POTS)

POTS represents a frequently overlooked yet common autonomic dysfunction in long COVID patients. It affects approximately 31% of individuals with long COVID. This condition manifests as an abnormal heart rate increase upon standing—specifically a rise of ≥30 beats per minute within 10 minutes of standing, often exceeding 120 beats per minute, without corresponding blood pressure drops.

POTS disproportionately affects younger individuals, primarily women. In one study, POTS patients were significantly younger (average age 40.0 years) than non-POTS long COVID patients (47.0 years), with 91% being female.

During walking tests, POTS patients show significantly higher heart rates both during exercise and recovery periods. Their physical activity levels are markedly lower than other long COVID patients, as measured by standardized scales.

The condition creates a troubling cycle: orthostatic intolerance leads to decreased activity, which causes cardiovascular deconditioning, which then worsens POTS symptoms. Many patients with POTS report being unable to stand for prolonged periods, experiencing dizziness, fatigue, and palpitations that severely limit normal activities.

For most individuals, these musculoskeletal challenges of long COVID represent an ongoing struggle requiring comprehensive management approaches and lifestyle adaptations.

Understanding the Psychological Side of Pain

Beyond physical symptoms, the psychological impact of post-COVID musculoskeletal disorders creates an additional burden for patients. The mind-body connection plays a crucial role in how pain is perceived, processed, and managed.

Depression and anxiety in chronic pain

The mental health toll of Long COVID extends far beyond temporary emotional distress. Research shows that between 6% and 18% of COVID-19 survivors develop post-traumatic stress disorder (PTSD) within three months of recovery. More broadly, anxiety and depression rank as the most prevalent psychiatric outcomes 6-12 months post-infection.

Indeed, the psychological burden for COVID survivors is multifaceted—encompassing direct disease impacts, long-term health consequences, and social implications. This creates what researchers call a “vicious cycle” where pain exacerbates mental health issues, which in turn intensify pain perception.

Studies demonstrate that COVID-19 survivors experiencing social difficulties have heightened risk for anxiety and depression. For instance, Black individuals with Long COVID showed increased anxiety and depression related to financial burdens, employment challenges, food insecurity, and housing instability. This underscores how socioeconomic vulnerabilities compound psychological distress.

The relationship between back pain and mental health deterioration during the pandemic illustrates this connection. People with chronic back pain were 3.5 times more likely to develop anxiety and 1.8 times more likely to develop depression compared to those without such pain.

Fear of movement and kinesiophobia

One particularly troubling psychological phenomenon among COVID survivors is kinesiophobia—the irrational fear of movement. Patients with post-COVID syndrome score significantly worse on the Tampa Scale for Kinesiophobia compared to control groups.

This fear creates a paradoxical situation: patients avoid movement to prevent pain, yet this avoidance ultimately worsens their condition. As movement decreases, muscle weakness increases, creating a downward spiral of physical deterioration.

The origins of this fear may be rooted in traumatic illness experiences. Some patients report “freezing” with trembling limbs during activities—physical manifestations of psychological distress. Others describe how fear prevents them from attempting normal activities, leading to further deconditioning.

Interestingly, functional movement disorders sometimes develop as expressions of the inability to communicate fear verbally, forcing patients to express it through their bodies instead. This explains why some patients develop tremors and abnormal movements during isolation periods even after recovering from the virus itself.

Cognitive fatigue and brain fog

Among the most distressing psychological symptoms is “brain fog”—a colloquial term describing significant neurocognitive impairment affecting thinking, information processing, and concentration. Approximately 7.2% of COVID survivors report this debilitating symptom.

Cognitive difficulties manifest in various ways:

  • Inability to multitask
  • Difficulty processing information
  • Forgetfulness
  • Problems with focus and concentration

Alongside mental fatigue, reduced activity in specific brain regions (particularly the left superior temporal gyrus) correlates with cognitive deficits. Some evidence suggests the SARS-CoV-2 virus disrupts brain homeostasis through neuroinflammatory mechanisms that persist beyond viral clearance.

A particularly concerning discovery is blood-brain barrier disruption, which can persist up to a year after infection. Research using specialized MRI techniques found evidence of a “leaky” blood-brain barrier in participants with Long COVID brain fog, often associated with reduced global brain volume.

For most patients, brain fog eventually resolves within 6-9 months, though for some it persists 18 months or longer. Risk factors for developing brain fog include female sex, respiratory problems during initial infection, and ICU admission.

The combination of physical pain, psychological distress, and cognitive dysfunction creates significant challenges for COVID survivors. Effective treatment must correspondingly address both the physical and psychological dimensions of recovery.

What Helps: Treatment and Recovery Options

Effective recovery from post-COVID musculoskeletal disorders typically requires a multi-faceted approach tailored to individual symptoms and severity. Fortunately, research has identified several evidence-based strategies that can significantly improve outcomes for those struggling with persistent symptoms.

Physiotherapy and graded exercise

Physiotherapy stands as a cornerstone treatment for addressing long COVID musculoskeletal issues. Studies demonstrate that tailored exercise programs can improve not only muscle strength but also flexibility and cardiovascular fitness. Therapists often employ manual therapy to enhance joint mobility and reduce pain in patients experiencing musculoskeletal discomfort.

Interestingly, inspiratory muscle training has shown particularly promising results. In studies lasting at least 6 weeks, participants demonstrated statistically significant improvements in physical function. For instance, a 12-week home program of inspiratory muscle training yielded substantial benefits for respiratory function.

Importantly, exercise must be carefully calibrated. Experts recommend starting at low to moderate intensity with limited duration, typically scoring no higher than 4/10 on the Borg Scale CR10 for shortness of breath and fatigue.

Anti-inflammatory treatment in long COVID

Among available anti-inflammatory approaches, metformin shows the strongest clinical evidence with substantial reductions in long COVID incidence (42% to 63%). Additionally, low-dose naltrexone (LDN) demonstrates effectiveness in improving fatigue, post-exertional malaise, and pain.

Other promising options include:

  • Dexamethasone, which reduces fatigue by 33% and shortens median symptom duration (133 days vs. 271 days)
  • Omega-3 fatty acids for improving mental health and musculoskeletal symptoms
  • L-Arginine combined with vitamin C, with 94.9% of patients reporting absence of fatigue

Nutritional support and hydration

Research indicates a 40% prevalence of at least one micronutrient deficiency among patients with post-COVID musculoskeletal manifestations. Iron, copper, and selenium deficiencies significantly correlate with symptom severity.

The arthritis group specifically showed higher prevalence of deficiencies compared to those with mild symptoms: iron (52.3% vs. 35%), selenium (56.5% vs. 14.1%), and copper (56.5% vs. 3.3%). Zinc plays a crucial role in immune modulation, with deficiencies leading to reduced natural killer cells and impaired immunity.

Pain education and pacing strategies

Educating patients about energy conservation and pacing represents a fundamental component of recovery. Physical therapists provide essential guidance on avoiding overexertion while optimizing daily activities. This approach helps manage the characteristic fluctuating nature of symptoms.

Proper pacing helps break the “boom-bust” cycle where patients overexert themselves on good days, leading to subsequent crashes. Accordingly, the goal is integrating physical activity into daily routines rather than treating it as a separate task, leading to more sustainable improvement.

Building a Personalized Rehab Plan

Creating a tailored rehabilitation program represents a crucial step for recovering from post-COVID musculoskeletal disorders. A systematic approach helps patients move from assessment to measurable recovery.

Assessing baseline function

A comprehensive evaluation forms the foundation of effective rehabilitation. Healthcare providers should conduct thorough history and physical examinations focusing specifically on functional status. Standardized assessment tools prove invaluable at this stage:

  • WHO post-COVID-19 functional scale for overall function
  • Montreal Cognitive Assessment (MOCA) for cognitive impairments
  • Barthel Index for activities of daily living (higher scores indicate greater independence)
  • Functional Independence Measure (FIM) for measuring recovery gains

Setting realistic goals

Rehabilitation goals must be highly individualized, addressing specific needs, resources, and abilities of each person. Firstly, healthcare providers should establish feasible short and long-term goals after thorough discussion with the patient and caregivers. As a matter of fact, shared decision-making empowers patients and increases adherence to rehabilitation plans.

Tracking progress and setbacks

Regular monitoring enables timely adjustments to rehabilitation strategies. Patients should be assessed at 12 weeks post-discharge with evaluations including chest X-ray, pulmonary function tests, and 6-minute walking tests. Henceforth, multidisciplinary teams can modify programs based on outcomes. Importantly, post-exertional symptom exacerbation and orthostatic hypotension require careful monitoring during exercise to prevent setbacks.

Conclusion

Post-COVID Musculo-Skeletal Disorders represent a significant health challenge affecting millions worldwide. Though originally perceived as primarily a respiratory illness, COVID-19 clearly impacts multiple body systems, particularly the musculoskeletal framework. The evidence points to a complex interaction between direct viral damage, inflammatory responses, and inactivity-related deconditioning that collectively contributes to persistent symptoms.

Many patients face a challenging journey from diagnosis through recovery. Fatigue, muscle weakness, joint pain, and sleep disturbances often persist long after the acute infection resolves. Additionally, these physical symptoms frequently coincide with psychological challenges such as depression, anxiety, and kinesiophobia, creating a multifaceted condition requiring comprehensive care.

Understanding the underlying mechanisms proves essential for effective management. The cytokine storm and persistent low-grade inflammation damage tissues and potentially trigger autoimmune responses, while medications used during treatment sometimes worsen musculoskeletal problems rather than alleviating them.

Recovery typically requires a tailored, multidisciplinary approach. Physiotherapy with carefully graded exercise, anti-inflammatory treatments, nutritional support, and pain education all play crucial roles in rehabilitation. Most importantly, patients must establish realistic goals based on thorough baseline assessments while tracking progress regularly.

The path toward recovery might seem daunting, yet proper management strategies offer real hope. Patients who follow structured rehabilitation programs generally show measurable improvements over time. Healthcare providers must recognize both the physical and psychological dimensions of these disorders while adapting treatment plans to individual needs.

Post-COVID musculoskeletal disorders will undoubtedly remain a significant health concern for years to come. Nevertheless, continued research and evolving treatment protocols promise better outcomes for those affected. Through early intervention, comprehensive care, and patient-centered approaches, those suffering from these debilitating conditions can find meaningful relief and gradually reclaim their quality of life.

Key Takeaways

Post-COVID musculoskeletal disorders affect millions globally, with symptoms persisting months after recovery. Understanding these complex conditions and implementing proper management strategies can significantly improve patient outcomes and quality of life.

• COVID-19 directly attacks muscles and bones through ACE2 receptors, causing fiber damage and bone loss even in asymptomatic cases • Persistent inflammation drives ongoing symptoms with cytokine storms creating chronic low-grade inflammation that damages tissues for months • Early recognition is crucial – fatigue (63%), muscle pain (28%), and joint pain (14.8%) are key warning signs requiring prompt intervention • Exercise intolerance and POTS are common affecting 31% of long COVID patients, creating cycles of deconditioning and worsening symptoms • Comprehensive treatment works best combining graded physiotherapy, anti-inflammatory medications, nutritional support, and pacing strategies • Personalized rehabilitation plans are essential with baseline assessments, realistic goals, and regular progress monitoring for optimal recovery

Recovery requires patience and multidisciplinary care, but structured rehabilitation programs show measurable improvements over time. The key is addressing both physical symptoms and psychological impacts through evidence-based approaches tailored to individual needs.

FAQs

Q1. What are the most common musculoskeletal symptoms experienced after COVID-19? The most common post-COVID musculoskeletal symptoms include fatigue (affecting up to 63% of survivors), muscle pain (28%), and joint pain (14.8%). Many patients also report weakness, stiffness, and reduced exercise tolerance.

Q2. How long can musculoskeletal symptoms persist after recovering from COVID-19? Musculoskeletal symptoms can persist for months after the initial COVID-19 infection. Some patients experience symptoms for 6-9 months, while others may have issues lasting 18 months or longer. The duration varies significantly between individuals.

Q3. Can COVID-19 trigger autoimmune responses in the body? Yes, COVID-19 can trigger autoimmune responses. Approximately 9.5% of COVID-19 survivors report developing autoimmune diseases post-infection, with conditions like systemic lupus erythematosus, rheumatoid arthritis, and autoimmune thyroiditis being the most common.

Q4. What role does inflammation play in post-COVID musculoskeletal disorders? Inflammation plays a crucial role in post-COVID musculoskeletal disorders. The initial cytokine storm during infection can lead to tissue damage, while persistent low-grade inflammation contributes to ongoing symptoms. This chronic inflammation can cause continued muscle and joint pain, fatigue, and other musculoskeletal issues.

Q5. What are some effective treatment options for post-COVID musculoskeletal symptoms? Effective treatment options include physiotherapy with graded exercise programs, anti-inflammatory medications (such as metformin or low-dose naltrexone), nutritional support to address deficiencies, and pain education with pacing strategies. A personalized rehabilitation plan that combines these approaches and monitors progress regularly is often most effective.

October 30, 2025 / by Manu Mengi
Mirror Therapy

Mirror Therapy Guide: From Paralysis to Movement for Hemiplegia Patients

The effect of mirror therapy on hemiplegia patients represents a breakthrough in stroke rehabilitation. At least 85% of stroke patients experience hemiplegia, with upper-extremity function damaged in at least 69% of cases. Unfortunately, only 5 to 20% of stroke survivors attain complete functional recovery of their affected upper extremity.

In our search for more effective rehabilitation techniques, mirror therapy has emerged as a promising approach for hemiplegia. This technique has shown significant results, particularly in improving paretic upper-extremity function and activities of daily living in chronic stroke patients. Additionally, studies have demonstrated that combining mirror therapy with conventional treatments significantly improves manual dexterity, grasping, and transfer performance.

Throughout this guide, we will explore how mirror therapy works, examine the clinical evidence behind its effectiveness, and provide practical guidelines for implementing this therapy. Whether you’re a healthcare professional or someone affected by stroke, we’ll help you understand how mirror therapy can potentially transform the journey from paralysis to movement.

Understanding Hemiplegia and the Need for Upper Limb Recovery

Hemiplegia dramatically changes lives by causing paralysis on one side of the body, often resulting from damage to the brain or spinal cord. This devastating condition affects the face, arm, and leg on one side, with varying degrees of severity that can profoundly impact independence and quality of life.

What is hemiplegia and how it affects daily life

Hemiplegia manifests as weakness or complete paralysis on either the right or left side of the body. It frequently occurs after stroke, traumatic brain injury, or other central nervous system disorders that impair motor control. The condition can cause muscle weakness, stiffness, poor coordination, and sensory deficits on the affected side.

The impact on daily life is substantial. Patients often struggle with:

  • Basic self-care activities like dressing, eating, and personal hygiene
  • Maintaining balance and walking safely
  • Grasping and manipulating objects
  • Fine motor skills needed for writing or buttoning clothes
  • Speech and communication (if facial muscles are affected)

Furthermore, hemiplegia can lead to secondary complications including joint deformities, contractures, and pressure sores if not properly managed through rehabilitation. These physical limitations frequently cause emotional distress, anxiety, and decreased perception of health-related quality of life.

Why upper limb function is critical in stroke recovery

While 75-83% of surviving stroke patients regain walking ability, upper limb recovery presents a more challenging journey. This discrepancy exists because arm function requires complex coordination of muscles from shoulder to fingertips for grasping, holding, and manipulating objects.

Upper limb function plays an essential role in recovery for several reasons. First, most personal-care tasks and meaningful activities require bi-manual function—the cooperation of both hands working together. Without this ability, independence is severely compromised.

Second, studies show that arm motor impairment one year after stroke is associated with anxiety and poorer perception of health-related quality of life. Despite this importance, many stroke survivors report that upper limb rehabilitation receives less attention than lower limb mobility, especially after hospital discharge.

Consequently, about 40% of stroke survivors are left with a persistent lack of function in the upper limb, causing significant disability. Given that problems with arm function remain in 55% to 75% of patients three to six months post-stroke, improved rehabilitation approaches are urgently needed.

Challenges in traditional rehabilitation methods

Traditional rehabilitation approaches face several key limitations. Primarily, they often fail to fully restore complex functional independence in activities of daily living. While basic motor function may improve, the sophisticated coordination required for daily tasks remains elusive.

Another obstacle is the generalized nature of conventional therapies. Despite individualized treatment plans, traditional approaches may lack precision in targeting specific neural pathways or muscle groups. This can limit effectiveness for patients with complex impairments.

Moreover, rehabilitation plateaus commonly occur, where patients reach a point in recovery where progress becomes minimal. This plateau effect happens because conventional methods may inadequately stimulate neuroplasticity—the brain’s ability to form new neural connections crucial for ongoing recovery.

The rehabilitation landscape faces additional challenges including therapy monotony leading to decreased patient engagement, insufficient therapy duration, and service shortages. Many patients report dissatisfaction with the limited focus on arm recovery, especially after hospital discharge when community services become infrequent.

These limitations highlight why innovative approaches like mirror therapy deserve exploration—potentially offering new pathways to recovery where traditional methods have fallen short.

What is Mirror Therapy and How It Works

Mirror therapy stands as a remarkably simple yet powerful approach in stroke rehabilitation, offering hope to patients with limited or no voluntary movement in their affected limbs. This innovative technique uses visual illusions to stimulate the brain and promote recovery in ways traditional therapy cannot match.

Basic concept of mirror therapy

Mirror therapy (MT) employs a mirror placed in a patient’s midsagittal plane (the middle of the body), reflecting the non-paretic side as if it were the affected side. The unaffected limb performs movements while the affected limb remains hidden behind the mirror. As the patient looks into the mirror, they see the reflection of their healthy limb moving, creating a compelling illusion that their affected limb is also moving normally.

Clinicians typically implement this using a “mirror box” – a simple device with a mirror positioned vertically in the center. The affected limb is placed behind the mirror while the unaffected limb moves in front of it. This setup creates visual feedback that appears to show both limbs functioning properly, even though one remains still.

Unlike conventional rehabilitation methods requiring some degree of voluntary movement, MT can benefit completely plegic or severely paretic stroke survivors since it relies on visual rather than somatosensory stimuli. This makes it uniquely valuable for patients in early recovery stages.

Role of visual feedback and mirror neurons

The effectiveness of mirror therapy hinges on how our brains process visual information. The technique cleverly exploits the brain’s natural tendency to prioritize visual feedback over proprioceptive feedback regarding limb position. Through this mechanism, the brain receives information that appears to show normal movement in the affected limb.

Central to this process is the mirror neuron system (MNS) – specialized cells that fire both when performing an action and when merely observing that same action. These mirror neurons, comprising approximately 20% of all neurons in the human brain, are activated during MT sessions.

The MNS resides primarily in the frontotemporal region and superior temporal gyrus, discharging during goal-oriented hand actions or observation of similar actions. This action-observation facilitates the corticospinal pathway, thereby improving motor function by eliciting mental imagery and inducing motor learning.

In essence, watching the mirror image activates the same neural pathways that would normally control actual movement in the affected limb. This visual stimulation serves as a powerful surrogate for direct motor control.

Mirror Therapy & Neuroplasticity explained

Neuroplasticity – the brain’s remarkable ability to reorganize itself by forming new neural connections – forms the foundation of recovery after stroke. Mirror therapy directly stimulates this process through consistent visual feedback.

During MT sessions, multiple brain regions become engaged: the occipital lobe, dorsal frontal area, corpus callosum, bilateral premotor cortex, primary motor cortex, primary somatosensory cortex, and cerebellum. This widespread activation promotes reorganization and enhanced function in the damaged brain areas.

The motor areas of the lesioned hemisphere receive visuo-motor processing information through the parieto-occipital lobe. Meanwhile, the damaged motor cortex responds to mirror therapy in ways that may stimulate true motor recovery.

Additionally, MT helps normalize balance between the hemispheres after stroke by modulating the excitability of the primary motor cortex. Both the attempted movement of the affected limb and the passive observation of the mirror reflection influence motor cortex excitability.

Perhaps most importantly, mirror therapy helps prevent or reverse “learned non-use” of the paretic limb – a phenomenon where patients stop attempting to use the affected limb due to repeated failure. By providing positive visual feedback, MT reminds the brain of the limb’s potential function and encourages renewed efforts toward recovery.

Clinical Evidence: Effectiveness of Mirror Therapy in Stroke Patients

Multiple clinical studies validate mirror therapy’s effectiveness for stroke patients with hemiplegia. Research consistently shows this simple, cost-effective approach yields measurable improvements in several key areas of recovery.

Improvement in motor control and coordination after stroke

Scientific evidence indicates mirror therapy has a significant positive effect on motor function (SMD 0.47) and motor impairment (SMD 0.49) based on moderate-quality evidence. In practical terms, patients receiving mirror therapy show better recovery of the affected upper extremity compared to those receiving only conventional rehabilitation.

Randomized controlled trials demonstrate that patients undergoing mirror therapy alongside conventional treatment show significantly improved Fugl-Meyer Assessment Upper Extremity (FMA-UE) scores. According to one study, both experimental and control groups had continuous improvement in FMA-UE scores over time, but the experimental group receiving mirror therapy showed significantly higher scores after just 2-4 weeks of intervention.

For chronic stroke patients specifically, mirror therapy significantly enhances motor ability in the upper extremity as evidenced by multiple clinical trials. The improvements extend beyond simple movements to include complex coordination tasks necessary for everyday functioning.

Functional outcome after Mirror Therapy

Regarding functional outcomes, mirror therapy shows clear benefits for improving manual dexterity, gross and fine motor movements, and proximal motor control. Studies report improved speed in upper limb movements after just one session of intensive mirror therapy.

Importantly, bimanual mirror therapy (using both hands) shows more significant improvement than unimanual approaches. Research indicates a significant difference in motor function (0.298) in favor of bimanual mirror therapy compared with controls, whereas no significant effect was found for unimanual mirror therapy.

Activities of daily living improvement after Mirror Therapy

The impact on daily functioning presents one of the most compelling arguments for mirror therapy. Moderate-quality evidence shows mirror therapy improves activities of daily living (SMD 0.48). These improvements remain stable over time, with benefits maintained for up to six months post-treatment.

Self-care abilities specifically show statistically significant differences between mirror therapy and control groups. In fact, patients receiving mirror therapy demonstrated functional ability scores 0.92 units higher than those receiving only conventional therapy.

Grip strength improvement with Mirror Therapy

Numerous studies report improved grip force following mirror therapy interventions. This improvement in hand strength translates to better ability to manipulate objects in daily life. Beyond raw strength, mirror therapy enhances hand dexterity as measured by assessments like the Box and Block Test, which shows significant improvements for experimental groups following treatment.

Notably, these grip strength improvements occur alongside enhancements in tactile sensation and temperature discrimination, addressing both motor and sensory deficits simultaneously.

Designing a Mirror Therapy Program for Hemiplegia

Creating an effective mirror therapy program requires careful attention to several key elements. Structuring sessions appropriately can maximize neuroplastic changes and functional recovery for hemiplegia patients.

Duration & frequency of Mirror Therapy sessions

Research indicates varying optimal dosages for mirror therapy. Most successful studies implement 4-week intervention periods with 3-5 sessions weekly. Individual sessions typically range from 15-50 minutes, with some studies suggesting 35 minutes daily as the maximum tolerable dose when frequency is set at seven days per week. For lower extremity treatment, sessions commonly last between 15 minutes and 1 hour for 5-6 days weekly. Overall intervention periods vary from 1-8 weeks, with 50% of studies using a 4-week timeframe.

Rehabilitation exercises for hemiplegic arm

Mirror therapy exercises generally fall into two categories:

  • Simple movements: Wrist extension, finger flexion/extension, and forearm rotation
  • Complex movements: Reaching, grasping, and object manipulation

The mirror setup typically uses either mirror boxes (3D structures hiding the affected limb) or mirror frames placed vertically between arms. Patients observe the unaffected limb’s reflection while attempting to move both limbs simultaneously.

Task-oriented training with Mirror Therapy

Task-oriented mirror therapy substantially outperforms simple mirror exercises for improving upper extremity function. Initially, studies comparing simple movement-based MT versus task-oriented MT revealed that patients receiving task-oriented training maintained improvements even after therapy conclusion, whereas gains from simple MT weren’t sustained. Task-oriented exercises involve functional movements associated with daily living activities, providing more meaningful context for neural reorganization.

Combining Mirror Therapy with conventional physiotherapy

Combining mirror therapy with conventional rehabilitation yields the most positive outcomes. One effective approach uses MT as “priming” for task-specific training, producing meaningful clinical improvements in upper extremity function and occupational performance. Some studies implement MT as a self-administered home therapy complementing clinic-based rehabilitation, with successful protocols including 2 weekly clinic sessions plus 4 weekly home sessions.

Nevertheless, evidence regarding combining MT with electrical stimulation remains inconclusive, highlighting the need for further high-quality research on integrated approaches.

Advanced Approaches and Future Directions

Innovative approaches are enhancing mirror therapy’s potential beyond its traditional applications. These advancements offer new possibilities for patients with varying needs and recovery stages.

Virtual reality & Mirror Therapy combination

Virtual reality (VR) takes mirror therapy to new heights by creating immersive environments that stimulate motor learning and neuroplasticity. This VR-based mirror therapy (VRMT) displays a reversed image of the unaffected limb in a virtual space. Importantly, VR offers a significantly larger movement area compared to conventional mirrors. Studies indicate that combining these approaches yields promising results, with gamified sessions proving particularly motivating for patients. Although SUS ratings vary across studies, most patients find VRMT both acceptable and engaging.

Difference between Mirror Therapy & motor imagery

While both techniques harness visual processing, their applications differ substantially. Motor imagery (MI) requires patients to mentally rehearse movements without physical execution. Research reveals MI works better for patients with mild cognitive impairment, whereas mirror therapy proves more effective for those with severe cognitive deficits. For phantom limb pain, both approaches reduce discomfort, yet mirror therapy demonstrates superior improvement (7.07±1.74 to 2.74±0.77) compared to mental imagery (7.85±0.76 to 5.87±1.41).

Limitations and considerations for different patient types

Despite promising results, several challenges persist. Some patients experience cybersickness with VR implementations. Clinicians report difficulty identifying appropriate candidates and developing stage-specific goals. Likewise, user preference for familiar therapies sometimes limits adoption of new techniques. Technical limitations of current systems, including hardware constraints, may also reduce effectiveness.

Conclusion

Mirror therapy stands as a remarkable breakthrough in stroke rehabilitation, offering hope where traditional approaches often fall short. Throughout this guide, we’ve explored how this simple yet powerful technique can transform recovery journeys for hemiplegia patients. The evidence clearly demonstrates significant improvements in motor control, functional outcomes, daily living activities, and grip strength when mirror therapy is implemented properly.

Undoubtedly, the success of mirror therapy lies in its ability to harness neuroplasticity through visual feedback. Rather than requiring initial voluntary movement, this approach cleverly engages mirror neurons and stimulates brain reorganization. This makes it particularly valuable for patients with severe paralysis who might otherwise have limited rehabilitation options.

Setting up an effective mirror therapy program requires careful attention to duration, frequency, and exercise selection. Most successful protocols implement 3-5 weekly sessions over a 4-week period, with each session lasting 15-50 minutes. Additionally, task-oriented training shows superior long-term benefits compared to simple movements, especially when combined with conventional physiotherapy.

Emerging technologies like virtual reality further expand mirror therapy’s potential by creating immersive environments that enhance engagement and motivation. Still, clinicians must consider individual patient factors when selecting the most appropriate approach.

Despite challenges in implementation and some technical limitations, mirror therapy represents a cost-effective, evidence-based intervention that deserves consideration in comprehensive rehabilitation programs. For stroke survivors and their caregivers, this approach offers a tangible path from paralysis to movement, potentially restoring function and improving quality of life when traditional methods have reached their limits.

Key Takeaways

Mirror therapy offers a revolutionary approach to stroke rehabilitation, using visual illusions to stimulate brain recovery and restore function in paralyzed limbs.

• Mirror therapy works by reflecting the healthy limb’s movement, tricking the brain into believing the paralyzed limb is moving normally

• Clinical evidence shows significant improvements in motor control, daily living activities, and grip strength within 2-4 weeks of treatment

• Optimal programs include 3-5 sessions weekly for 4 weeks, with 15-50 minute sessions focusing on task-oriented exercises

• Unlike traditional therapy, mirror therapy benefits completely paralyzed patients since it relies on visual rather than physical movement

• Combining mirror therapy with conventional rehabilitation yields the best outcomes for long-term functional recovery

This breakthrough technique harnesses neuroplasticity through mirror neurons, offering hope to the 85% of stroke patients who experience hemiplegia. By providing positive visual feedback, mirror therapy helps prevent learned non-use and encourages the brain to rebuild neural pathways essential for movement recovery.

FAQs

Q1. How does mirror therapy work for stroke patients with hemiplegia?
Mirror therapy creates a visual illusion by reflecting the movement of the unaffected limb, tricking the brain into believing the paralyzed limb is moving normally. This stimulates brain regions responsible for movement and sensation, promoting neuroplasticity and functional recovery.

Q2. What are the benefits of mirror therapy for stroke rehabilitation?
Mirror therapy has shown significant improvements in motor control, functional outcomes, daily living activities, and grip strength. It can benefit even completely paralyzed patients and helps prevent learned non-use of the affected limb.

Q3. How long and how often should mirror therapy sessions be conducted?
Most successful mirror therapy programs implement 3-5 sessions weekly for 4 weeks, with each session lasting 15-50 minutes. However, the exact duration and frequency may vary based on individual patient needs and recovery stages.

Q4. Can mirror therapy be combined with other rehabilitation techniques?
Yes, combining mirror therapy with conventional physiotherapy often yields the best outcomes. It can be used as a “priming” technique before task-specific training or as a complementary home-based therapy alongside clinic sessions.

Q5. Are there any advanced approaches to mirror therapy?
Virtual reality-based mirror therapy (VRMT) is an innovative approach that creates immersive environments for motor learning. While it offers larger movement areas and can be more engaging, some patients may experience cybersickness. The choice between traditional mirror therapy and VRMT depends on individual patient factors and preferences.

October 30, 2025 / by Manu Mengi
Your Step-by-Step Guide to Physiotherapy in Facial Palsy Treatment - Dr. Aayushi

Your Step-by-Step Guide to Physiotherapy in Facial Palsy Treatment

Bell’s palsy and other forms of facial nerve paralysis affect 11-40 people per 100,000 annually, with physiotherapy in facial palsy emerging as a crucial treatment approach. Unfortunately, one in three patients (29%) experiences poor recovery, resulting in permanent facial function deficits. This can lead to significant psychological distress, depression, and even social alienation as people withdraw from public-facing roles.

Fortunately, the evidence, though limited in size, strongly supports the use of facial palsy exercises and rehabilitation techniques to accelerate recovery and minimise adverse outcomes. In fact, approximately 70% of people with Bell’s palsy recover completely without treatment within 3-6 months, but with proper physiotherapy interventions, we can potentially improve outcomes for the remaining 30%. Additionally, research indicates that facial exercises may significantly improve facial function, especially when combined with other treatments.

In this comprehensive guide, we’ll walk through everything you need to know about physiotherapy for facial nerve paralysis – from recognising symptoms to implementing advanced rehabilitation techniques for recovery of facial symmetry. Whether you’re dealing with post-stroke facial palsy or Bell’s palsy (which accounts for about 60-75% of all facial paralysis cases in the United States), this step-by-step approach will help you understand how neurological rehabilitation can restore both function and confidence.

Ready to begin your recovery journey? Trust your care to  Mohali's Top Physiotherapist at The Brigit Clinic. We create personalised plans for optimal results. Schedule Your Assessment Today!

Step 1: Recognising the Signs of Facial Palsy

Facial palsy can appear suddenly or develop gradually, causing varying degrees of muscle weakness on one or both sides of the face. Recognising these symptoms early allows for prompt intervention, potentially improving long-term outcomes through timely physiotherapy and medical care.

Early symptoms to watch for

The onset of facial palsy symptoms can be quite dramatic – appearing overnight or developing over two to three days. In other cases, symptoms may emerge gradually over weeks or even months. Initially, you might notice:

  • Drooping or flattening on one side of the face
  • One-sided smile or difficulty making facial expressions
  • Problems closing your eye completely on the affected side
  • Facial droop affecting the brow, eye, cheek, and mouth
  • Drooling due to reduced muscle control
  • Pain around the jaw or behind the ear
  • Increased sensitivity to sound
  • Headache or slight fever

The severity can range from mild weakness to complete paralysis of facial muscles. Furthermore, some people experience numbness or heaviness in their face, yet can still feel touch and temperature sensations. Changes in tear production and saliva may also occur, along with potential taste loss.

For most people with Bell’s palsy (which accounts for many facial palsy cases), symptoms reach their maximum severity within 48-72 hours. During this period, you’ll likely notice the most pronounced facial asymmetry.

When to seek medical help

If you experience any sudden facial weakness or drooping, seek medical attention immediately. This is crucial because facial paralysis can sometimes indicate a serious condition like stroke, even though most cases turn out to be Bell’s palsy.

Call emergency services (911) immediately if facial weakness is accompanied by:

  • Weakness or paralysis in arms or legs
  • Difficulty walking or coordination issues
  • Slurred speech or difficulty speaking
  • Blurred or double vision
  • Suddenly, a severe headache
  • Memory loss or confusion

Generally, even if facial weakness is your only symptom, you should visit your doctor as soon as possible for proper diagnosis. This is particularly important since early treatment with steroids (within 72 hours) improves outcomes for Bell’s palsy – 83% of treated patients achieve full recovery compared to only 72% of untreated patients.

Additionally, seek prompt medical evaluation if symptoms develop slowly over weeks or months, as this might indicate an underlying condition requiring specialised treatment. Similarly, contact your healthcare provider immediately if you notice painful vesicular rashes in or around your ear, mouth, or scalp, as this could indicate Ramsay Hunt Syndrome requiring antiviral medication.

Post-stroke facial palsy indicators

Central facial paralysis (CFP) affects approximately 45% of stroke patients. Unlike Bell’s palsy, post-stroke facial weakness typically affects only the lower part of the face – the area below the eye clefts. Moreover, you might observe:

  • The ability to wrinkle your forehead and raise eyebrows remains intact
  • Weakness primarily affects the mouth and cheek region
  • Associated symptoms like dysphagia (swallowing difficulties) and dysarthria (speech problems)
  • Increased muscle tension and decreased muscle strength

Post-stroke facial palsy often coincides with other stroke symptoms previously mentioned. Consequently, prompt medical care is essential as this represents a medical emergency requiring immediate treatment to minimise brain damage.

Beyond physical symptoms, facial paralysis frequently causes psychological impacts. Patients with facial paralysis are more likely to experience anxiety and depression, which may subsequently affect motivation during rehabilitation. Therefore, recognising and addressing both physical and emotional aspects is vital for comprehensive recovery.

Noticed sudden facial drooping or weakness? Early intervention is critical. Contact the leading Physiotherapy Clinic in Mohali for prompt evaluation and care. Call us at 📞 0172 - 3137922.

Step 2: Getting a Proper Diagnosis

After noticing facial weakness symptoms, obtaining an accurate diagnosis is crucial for effective physiotherapy in facial palsy treatment. A proper diagnosis determines both the cause and severity of your condition, directly influencing your rehabilitation plan.

Initial clinical assessment

The diagnostic journey typically begins with a thorough clinical examination by a healthcare professional. Your doctor will visually examine your face to assess the extent of paralysis and muscle control. During this assessment, they’ll ask you to perform specific facial movements like smiling, blinking, raising your eyebrows, and closing your eyes.

The clinical evaluation critically distinguishes between central nervous system causes (stroke, brain tumour, multiple sclerosis) and peripheral causes (Bell’s palsy, ear infections, facial nerve tumours). One key differentiator is the pattern of weakness – central facial paralysis typically spares the forehead due to bilateral innervation of forehead muscles.

Your doctor will gather important historical information, including:

  • When you first noticed symptoms
  • How quickly does paralysis develop
  • Whether you have any muscle control in the affected areas
  • Associated symptoms like hearing loss or tinnitus

Several specialised clinical tests may be performed, including the blink test (corneal reflex), Schirmer test (assessing lacrimation), stapedial reflex test, and taste tests. These evaluations help pinpoint the location of nerve damage within the facial nerve pathway.

Imaging and nerve conduction tests

Following the initial assessment, your physician may order additional diagnostic tests. Although imaging studies aren’t typically indicated in early evaluation of Bell’s palsy, they become necessary with certain warning signs – parotid mass, facial twitching, or additional neurologic symptoms.

MRI scanning proves particularly valuable for examining the entire facial nerve pathway. It can identify swelling, compression, or growths affecting the nerve, and is especially useful for imaging the cerebellopontine angle. Within the first month of paralysis onset, MRI with gadolinium contrast may show abnormal enhancement of various nerve segments.

CT scans are primarily recommended if complications from middle ear infection, necrotising otitis externa, head trauma, or malignancy are suspected.

Nerve conduction studies offer an objective assessment of nerve function and integrity. These include:

  • Electroneurography (ENoG): Measures compound muscle action potential (CMAP) by stimulating the facial nerve at the stylomastoid foramen. Ideally performed within 14 days of onset, it helps determine the percentage of nerve degeneration by comparing affected and unaffected sides.
  • Electromyography (EMG): Evaluates electrical impulses along nerves and muscle tissue, helping assess weakness or paralysis in facial muscles. Unlike ENoG, EMG becomes most helpful 2-3 weeks after palsy onset and loss of nerve excitability.

The amplitude loss percentage calculated from nerve conduction studies provides valuable prognostic information. An abnormal facial nerve ultrasound has a negative predictive value of 77% for poor recovery (House-Brackmann Grade II or worse at 3 months).

Grading the severity of facial nerve paralysis

Once diagnosed, physicians use standardised scales to quantify the degree of facial paralysis. The House-Brackmann scale, approved by the American Academy of Otolaryngology-Head & Neck Surgery, serves as the reference standard. This six-point scale grades facial function from normal (Grade I) to complete paralysis (Grade VI).

The House-Brackmann classification evaluates both function at rest and with effort, making it comprehensive yet simple enough for clinical settings. Nevertheless, it has limitations in sensitivity for recording clinically significant changes.

For a more detailed assessment, the Sunnybrook facial grading system offers advantages. It evaluates facial symmetry at rest, voluntary movements, and synkinesis using a 0-100 scale (where 100 represents normal function). Physiotherapists often prefer this system for its sensitivity and specific assessment of synkinesis.

Other systems include the Sydney facial grading system, which assesses facial actions based on individual branches of the facial nerve. These standardised assessments provide objective measures for tracking progress throughout your physiotherapy journey.

Need a clear diagnosis and a path forward? Our Best Physio Clinic in Mohali uses advanced assessments to create your personalised treatment plan. Visit Our Clinic Page to Learn More.

Step 3: Starting Physiotherapy – What to Expect

Beginning physiotherapy for facial palsy involves several important steps designed to assess your condition, establish appropriate goals, and create an effective treatment plan. Understanding what to expect can help ease anxiety as you start this crucial rehabilitation journey.

First session: what happens

The initial physiotherapy session primarily focuses on a comprehensive assessment. Your therapist will gather detailed information about your symptoms, any recovery progress you’ve noticed, and other relevant medical history. This thorough evaluation helps determine the most effective treatment approach for your specific condition.

During this assessment, your therapist may use various techniques to evaluate your facial nerve function:

  • Surface electromyography (sEMG) – Painless sticky electrodes placed on your face measure electrical activity in various muscles when you’re still and when attempting movements like raising your eyebrows, closing your eyes, smiling, or whistling
  • Facial movement evaluation – The therapist examines muscle tone, normal movements, and any abnormal movements
  • Muscle condition assessment – Noting whether facial muscles are weak and floppy or short and tight
  • Eye health examination – Particularly important, as your therapist will provide advice about protecting your eyes from damage

At the end of the assessment, your therapist might recommend additional investigations if necessary, communicating with your referring doctor about further procedures.

Setting goals with your therapist

After completing the assessment, your therapist will help you understand how your facial nerve has been affected and the recovery process ahead. This educational component is crucial, as you’ll need to become intimately familiar with your face’s movements, appearance, and functions.

Your physiotherapist will classify your condition into specific treatment categories that guide goal-setting:

  • Initiation
  • Facilitation
  • Movement control
  • Relaxation

Together, you’ll establish realistic goals based on standardised assessment tools like the Facial Grading System (FGS), Facial Disability Index (FDI), House–Brackmann Scale, or Photoshop method. These tools help determine specific treatment objectives tailored to your symptoms.

Your therapist will undeniably emphasise understanding your facial motor dysfunction, teaching you to recognise desired movement patterns versus those to avoid. This awareness, especially when combined with biofeedback techniques, can minimise your risk of developing facial palsy complications.

Creating a personalised treatment plan

Based on your assessment results, the physiotherapist will develop a customised treatment plan addressing your specific needs. This plan typically includes a combination of approaches:

Core components often include:

  • Active-assisted exercises with small, controlled movements
  • Massage and stretching techniques to improve blood flow
  • Facial retraining therapy to strengthen muscles and teach proper function
  • Educational components about recovery processes and warning signs

For acute facial palsy (within the first 72 hours to 2 weeks), a multimodal approach involving a multidisciplinary team offers optimal results. Meanwhile, in the first 5 months after onset, your treatment plan will prioritise eye care to prevent corneal damage.

Your physiotherapist will explain that the quality of exercise performance matters more than quantity. Understanding this principle helps prevent abnormal movement patterns like synkinesis, which can develop if exercises aren’t performed correctly. Unlike other body muscles, facial muscles lack intrinsic feedback information, making precise, gentle rehabilitation through neuroplasticity essential.

Throughout your therapy journey, your physiotherapist will use photos, videos, and specialised software to track and visualise your progress. Most exercises should be performed in short sessions, typically three to four times daily, with up to 30 repetitions per exercise. Following your therapist’s recommendations for home practice is vital—repeating exercises several times daily gives facial muscles the best chance to relearn natural movements.

Uncertain about what physiotherapy entails? Let our expert team at the Best Physiotherapist Clinic in Mohali guide you through every step with compassion and expertise. Book your first session now!

Step 4: Core Exercises for Facial Muscle Recovery

Core exercises form the foundation of physiotherapy in facial palsy, directly targeting muscle weakness and coordination to restore function and appearance. These specialised techniques help activate muscles, promote circulation, and stimulate nerve regeneration while preventing unwanted complications.

Facial palsy exercises for symmetry

Rebuilding facial symmetry requires precise, controlled movements performed consistently over time. Essentially, these exercises help maintain muscle tone, reduce stiffness, improve mobility, prevent facial contractures, and develop better muscle control.

I recommend performing facial exercises 3-4 times daily in short sessions, with up to 30 repetitions per exercise. Accordingly, it’s best to:

  • Sit in front of a mirror to monitor your movements
  • Perform movements slowly and carefully
  • Use your fingers to gently assist affected muscles when needed
  • Stop immediately if you experience pain or discomfort

For optimal results, focus on specific muscle groups. Eyebrow exercises target the frontalis muscle, crucial for emotional expression. Eye exercises strengthen the orbicularis oculi muscle responsible for blinking. Nose exercises work the nasalis muscle, while lip and cheek exercises improve control of eating and speaking functions.

Stretching & strengthening routines

An effective strengthening routine should progress gradually as your control improves. Start with basic movements:

  1. Forehead workout: Gently lift your eyebrows while keeping your eyes open
  2. Eye control: Practice closing your eyelids tightly, creating wrinkles at the outer corners
  3. Nose exercises: Inhale deeply and sniffle, then wrinkle your nose and flare your nostrils
  4. Mouth control: Slowly pucker your lips together and push them forward

Throughout these exercises, use your fingers to prevent unwanted movement patterns or synkinesis, which could develop if exercises aren’t performed correctly.

Mirror therapy for coordination

Mirror therapy has emerged as a valuable technique for facial palsy rehabilitation. This approach uses visual feedback to stimulate different brain regions for movement, sensation, and pain.

During mirror therapy, you’ll perform facial neuromuscular retraining while observing your movements in a mirror. This creates visual stimulation to the brain, sending signals to move facial muscles repeatedly and preventing potential muscle contractures.

Research demonstrates mirror therapy’s effectiveness—patients receiving mirror therapy alongside standard rehabilitation showed significantly better results in House-Brackmann scores and quality of life compared to those receiving only traditional rehabilitation. One study found mirror therapy particularly helpful for improving face symmetry and decreasing synkinesis in the long term, with a quantifiable impact one year after onset.

EMG biofeedback in facial palsy

Electromyography (EMG) biofeedback provides an objective measurement of muscle activity, offering advantages over visual feedback alone. This technique uses surface electrodes placed on facial muscles to measure electrical activity during both rest and movement.

The biofeedback training typically spans two weeks, based on elements combined with Constraint-Induced Movement Therapy principles. Patients learn to perform facial movements more symmetrically while avoiding overly strong movements on the unaffected side and controlling unintended co-movements (synkinesis).

In a structured program, two bipolar foam hydrogel electrodes are attached to each side of the face, recording muscle activity in the cheek and mouth region. These electrodes connect to a biofeedback system that visualises muscle activity through feedback bars proportional to the activation level.

Studies show that biofeedback training leads to decreased overall muscle activity on both the synkinetic side and the contralateral side, demonstrating its effectiveness in facial muscle rehabilitation.

Struggling with facial symmetry? Our Physiotherapist in Mohali uses evidence-based techniques like mirror therapy and EMG biofeedback for effective recovery. Discover the difference expert care makes.

Step 5: Advanced Techniques for Better Results

Advanced rehabilitation techniques expand your facial palsy recovery options beyond basic exercises, often accelerating progress and addressing stubborn movement problems. These specialised approaches help patients who need additional intervention to achieve optimal facial function.

Neuromuscular re-education strategies

Neuromuscular facial re-education represents a sophisticated approach to facial rehabilitation that focuses on relearning movement patterns through specific feedback mechanisms. The process aims to facilitate proper muscle activity while suppressing abnormal movements that interfere with facial function.

This technique addresses a fundamental challenge in facial rehabilitation—facial muscles lack intrinsic feedback information (no internal sensory receptors), making it difficult to perform voluntary movements without external guidance. By providing visual feedback through mirrors or EMG biofeedback, your therapist helps you modify muscle activity by:

  • Increasing activation in muscles that should move but don’t
  • Decreasing activation in muscles that shouldn’t move but do

The approach relies heavily on neuroplasticity—your brain’s ability to reorganise itself by forming new neural connections. A 2011 study published in Neurology found that patients undergoing facial neuromuscular retraining experienced significantly better functional improvement than those who didn’t receive this intervention.

Electrical stimulation therapy

Electrical stimulation therapy remains one of the most debated advanced techniques in facial palsy rehabilitation. This approach delivers controlled electrical currents to promote nerve regeneration and preserve muscle mass during recovery.

Regarding effectiveness, results from animal studies appear promising—electrical stimulation reduced recovery time of the eye blink reflex by approximately 26% in one study. Remarkably, even a single session of stimulation proved as effective as multiple treatments for accelerating recovery.

Despite these encouraging findings, the clinical application remains contentious. Some clinicians assert that electrical stimulation improves recovery, yet others worry about potential adverse effects and increased synkinesis risk. Current research suggests electrical stimulation may be most beneficial for:

  • Preventing muscle atrophy in denervated muscles
  • Improving electrophysiological outcomes
  • Reducing recovery time by approximately 30-50%

For optimal results, different current parameters are required for innervated versus denervated muscles—pulse durations of 100-300 microseconds for innervated muscles compared to at least 10 milliseconds for denervated muscles.

Manual therapy and massage

Facial massage plays a critical role in maintaining tissue pliability throughout your recovery process. Regular massage helps keep your face supple as nerves regenerate, potentially reducing stiffness and other side effects.

A small-scale 2020 study published in Complementary Therapies in Clinical Practice found targeted massage techniques significantly improved facial symmetry and muscle function in Bell’s palsy patients over 8 weeks. Typical techniques focus on:

  • Lower facial muscles: Grasping the centre of the lips and moving them into different positions
  • Circular movements to improve circulation
  • Gentle stretching to maintain tissue elasticity

The basic principle behind massage therapy is improving blood circulation, reducing muscle tightness, and supporting nerve healing, particularly when combined with other physical therapy approaches.

Proprioceptive neuromuscular facilitation

Proprioceptive neuromuscular facilitation (PNF) represents another advanced option primarily known for limb rehabilitation but increasingly applied to facial palsy recovery. This technique uses patterns of movement and stretching to improve muscle function and coordination.

The current evidence for PNF in facial palsy treatment is limited but promising. A study examining patients receiving PNF with steroids showed faster clinical recovery (mean recovery time 70 days) compared to those receiving steroids alone (mean recovery time 124 days).

Typically, PNF is combined with other interventions rather than used alone. Studies have investigated PNF together with:

  • Medications (antivirals and corticosteroids)
  • Conventional treatment, including galvanic current stimulation
  • Nerve stimulation

Assessment tools like the House-Brackmann Scale, Synkinesis Assessment Questionnaire, and Facial Disability Index are commonly used to measure progress with PNF treatment.

Plateaued in your recovery? Explore advanced neuromuscular re-education and other techniques with the Best Physiotherapist in Mohali at The Brigit Clinic. Call 📞 0172 - 3137922 to Advance Your Treatment.

Step 6: Supporting Daily Function and Expression

Beyond mastering exercises and advanced techniques, physiotherapy in facial palsy must address daily functional challenges that significantly impact quality of life. Nearly one-third (29%) of patients experience permanent facial function deficits affecting critical activities, creating obstacles that specialised rehabilitation strategies can help overcome.

Speech improvement through physiotherapy

Facial paralysis often compromises speech clarity, especially for sounds requiring lip seal such as ‘b’, ‘p’, ‘m’, ‘v’, and ‘f’ consonants. Studies reveal that patients with unilateral facial palsy demonstrate significantly poorer articulation compared to healthy individuals.

Interestingly, the relationship between palsy severity and speech impacts isn’t straightforward—research indicates no direct correlation between the degree of facial palsy and its effect on communication. This underscores why individualised assessment by a speech-language therapist or physiotherapist with facial rehabilitation expertise remains vital.

Speech therapy typically incorporates:

  • Specific articulation exercises focusing on problematic consonants
  • Compensatory strategies to maximise intelligibility
  • Combined approaches with facial exercises to strengthen relevant muscles

Eating & drinking function recovery

Facial weakness creates substantial challenges during meals. The inability to form a proper lip seal makes containing food and fluids difficult, while weakened cheek muscles allow food to collect on the affected side. These complications often lead patients to avoid eating in social settings.

For improved eating and drinking, consider these practical techniques:

First, support your lower lip with transpore tape (2.5 cm width) positioned to lift toward the outer mouth corner. Cheek taping can likewise provide structural support during the flaccid recovery stage. Additionally, specialised tools like Kapi-cups—thin plastic mugs with cutouts allowing drinking without head-tipping—can dramatically improve fluid intake.

Dietary modifications prove equally important—choosing softer foods, avoiding mixed consistencies (like cereal in milk), and taking smaller bites all contribute to better mealtime experiences.

Eye protection & blinking recovery

Facial nerve paralysis frequently affects tear production and blinking ability, creating a serious risk for corneal damage. Eye protection represents the highest priority during early recovery (first 5 months).

Common eye protection approaches include:

  • Artificial tears are applied hourly to maintain moisture
  • Eye ointments for inflammation and soreness
  • Medical tape or eye patches to prevent drying from air conditioning or fans

For long-term blinking issues, eyelid weights offer a more permanent solution. Made from gold or platinum and implanted into the upper eyelid, these weights help restore proper blinking function. This procedure requires careful planning and precise implementation by facial plastic and oculoplastic surgeons.

Improvement in facial expressions

Facial expressions constitute the foundation of non-verbal communication, with their absence profoundly affecting social interactions. Patients living with incomplete recovery frequently experience psychological distress, depression, and social alienation.

Physiotherapy focuses on restoring expressiveness through neuromuscular retraining techniques using a mirror or EMG biofeedback. As recovery progresses, patients learn to refine control of specific muscle groups responsible for different expressions, gradually rebuilding their non-verbal communication repertoire.

Throughout rehabilitation, remember that improvement varies by individual. Seeking qualified professional guidance ensures you receive appropriate, personalised interventions tailored to your specific functional needs.

Difficulty with speech, eating, or eye closure? We specialise in restoring daily function. Find supportive and effective Physiotherapy in Mohali at our state-of-the-art clinic. Let us help you regain confidence.

Step 7: Home Care and Long-Term Maintenance

Successful facial palsy rehabilitation requires consistent practice at home, long after your supervised therapy sessions end. The daily exercises and self-care routines you perform become fundamental to your long-term recovery.

Daily home exercise routines

Home exercise programs should complement your professional therapy sessions. For optimal results, your therapist will typically prescribe:

  • 3 to 5 specific exercises targeting your affected areas
  • 5 to 10 repetitions of each exercise
  • Practice sessions twice daily

Remember that quality matters more than quantity. Indeed, all movements should be very gentle and performed with extreme care. Forceful attempts with weakened muscles can lead to complications like synkinesis or unwanted facial movements. Only practice exercises at home after you can perform them accurately and recognise when you’re doing them incorrectly.

Massage for facial muscles at home

Facial massage plays a vital role alongside exercises in maintaining healthy, mobile muscles throughout recovery. After learning proper techniques from your therapist, you can perform regular massages to:

  • Keep muscles supple and healthy
  • Lengthen muscles that have become short or tight
  • Improve circulation to support nerve healing

For optimal technique, use your palms and fingertips to massage the sides of your face in an upward motion. Throughout the process, use Vitamin E or jojoba oil to improve gliding motion without causing breakouts. Focus on sweeping motions rather than rubbing, as excessive rubbing may irritate skin and cause inflammation.

Tracking progress and setbacks

Keeping a photographic diary of your recovery provides objective evidence of improvement. As part of your monitoring:

  • Take baseline photos as soon as possible after diagnosis
  • Repeat photos every five days for the first three weeks
  • Continue with photos every two weeks thereafter

This visual documentation helps both you and your healthcare providers assess progress objectively, as daily observation makes subtle changes difficult to notice.

When to revisit your therapist

Schedule a follow-up with your therapist if:

  • You notice no recovery within three months
  • New abnormal movements develop
  • You experience increasing tightness or discomfort
  • You’ve completed your home program but plateaued

Above all, remember that recovery often progresses slowly, hence patience remains essential. Many patients don’t see initial improvement for several months, yet therapy remains effective even when started years after onset.

Need a sustainable home exercise plan? Get a tailored routine from our Physio Clinic in Mohali to ensure you practice correctly and safely between sessions. Your long-term recovery is our priority.

Step 8: Measuring Success and Adjusting Treatment

Tracking progress objectively forms the cornerstone of effective facial palsy rehabilitation, allowing both patient and therapist to make informed decisions about treatment adjustments.

Using outcome measures like FDI and Sunnybrook

Measuring facial palsy improvement requires standardised assessment tools. The House-Brackmann Scale (HBS) remains the most commonly used method for recording functional recovery, appearing in numerous studies. The Sunnybrook Facial Grading System offers greater sensitivity by evaluating resting symmetry, movement symmetry, and synkinesis on a 0-100 scale. Notably, physiotherapists often prefer this system specifically for its detailed assessment of synkinesis.

Patient-reported outcomes provide equally vital information. The Facial Disability Index (FDI) measures both physical function (FDIP) and social/well-being elements (FDIS). These scores help quantify quality of life impacts that clinical grades might miss.

Recovery of facial symmetry over time

Facial symmetry typically improves gradually with appropriate physiotherapy. Patients using mirror book therapy show approximately 25% increase in Facial Grading System scores, 21.6% improvement in FDIP, and 24.5% increase in FDIS. Voluntary movement scores specifically demonstrate significant increases between the 6th and 12th months of treatment.

Adapting therapy for chronic cases

Remarkably, facial rehabilitation benefits patients regardless of age, gender, or when treatment begins. For chronic cases, treatment modifications based on regular reassessment become essential. Surface-based measurement techniques can detect subtle symmetry improvements, guiding therapy adjustments even in long-standing cases. As treatment progresses, outcome measures help identify plateaus requiring fresh therapeutic approaches.

Want to accurately track your recovery? Our Physio Clinic Near Me in Mohali uses standardised tools like the Sunnybrook scale to measure success and adjust your plan for the best outcomes. Get a Progress Evaluation Today.

Conclusion

Facial palsy rehabilitation represents a journey rather than a quick fix. Though each person’s path to recovery differs, physiotherapy undoubtedly plays a crucial role in restoring both function and confidence. Throughout this guide, we’ve explored everything from recognising symptoms to implementing advanced rehabilitation techniques.

Patience remains essential during recovery. Most patients see significant improvement within 3-6 months, but complete rehabilitation might take longer, especially for the 30% who don’t recover spontaneously. Your commitment to consistent practice makes all the difference in your outcome.

Actually, physiotherapy for facial palsy works best as a comprehensive approach. Combining core exercises, neuromuscular re-education, and specialised techniques like mirror therapy or EMG biofeedback maximises your chances of regaining facial symmetry and function. These evidence-based approaches help reestablish neural pathways and muscle coordination through neuroplasticity.

Beyond physical recovery, physiotherapy addresses psychological aspects of facial palsy. Many patients experience social anxiety and depression due to changes in appearance and function. Consequently, rehabilitation must target both physical restoration and emotional well-being.

Remember that support exists regardless of when your facial palsy began. Research shows benefits from therapy even years after onset, so previous disappointments needn’t determine your future progress. Your physiotherapist can adjust your treatment plan as needed based on objective measurements and your personal goals.

Facial palsy might temporarily change how you interact with the world, but with proper physiotherapy, dedication to home exercises, and professional guidance, you can achieve significant functional improvement and regain your confidence. This step-by-step approach provides the roadmap—now your journey toward recovery can begin.

Key Takeaways

This comprehensive guide reveals evidence-based strategies for facial palsy recovery that can significantly improve outcomes when applied systematically.

• Early intervention matters most: Seek medical attention within 72 hours of symptom onset – patients receiving early steroid treatment achieve 83% full recovery versus only 72% without treatment.

• Quality over quantity in exercises: Perform facial exercises 3-4 times daily with gentle, controlled movements – forceful attempts can cause complications like synkinesis and unwanted facial movements.

• Mirror therapy accelerates recovery: Visual feedback through mirror exercises stimulates brain regions for movement and significantly improves facial symmetry while reducing long-term complications.

• Home practice determines success: Consistent daily exercise routines and facial massage maintain muscle health and support nerve healing throughout the recovery process.

• Recovery takes patience but works: While 70% recover naturally within 3-6 months, physiotherapy benefits patients regardless of age or when treatment begins – even years after onset.

The key to successful facial palsy rehabilitation lies in combining professional guidance with dedicated home practice, using evidence-based techniques that address both physical function and emotional well-being for comprehensive recovery.

FAQs

Q1. How long does it typically take to recover from facial palsy with physiotherapy?

A1. Recovery time varies, but most patients see significant improvement within 3-6 months of starting physiotherapy. Complete rehabilitation may take longer, especially for the 30% who don’t recover spontaneously. Consistent practice and patience are key to achieving the best outcomes.

Q2. What are some core exercises for facial muscle recovery?

A2. Core exercises include gentle movements targeting specific muscle groups, such as lifting eyebrows, closing eyes tightly, wrinkling the nose, and puckering lips. These should be performed 3-4 times daily in short sessions, with up to 30 repetitions per exercise, while monitoring in a mirror to ensure proper technique.

Q3. Can physiotherapy help with speech and eating difficulties caused by facial palsy?

A3. Yes, physiotherapy can significantly improve speech clarity and eating function. Techniques include specific articulation exercises, compensatory strategies for intelligibility, and methods to support lip seal and cheek muscles during meals. Specialised tools and dietary modifications may also be recommended.

Q4. Is electrical stimulation effective in facial palsy treatment?

A4. The effectiveness of electrical stimulation in facial palsy treatment is debated. Some studies suggest it can reduce recovery time by 30-50% and help prevent muscle atrophy. However, its clinical application remains controversial due to potential risks of adverse effects and increased synkinesis.

Q5. How can I track my progress during facial palsy rehabilitation?

A5. Progress can be tracked through standardised assessment tools like the House-Brackmann Scale and Sunnybrook Facial Grading System. Additionally, keeping a photographic diary with regular photos every few weeks provides visual evidence of improvement. Patient-reported outcome measures like the Facial Disability Index also help quantify quality of life impacts.

About Dr. Aayushi – Best Physiotherapist in Mohali

Dr. Aayushi is a highly skilled and compassionate physiotherapist dedicated to helping patients overcome the challenges of facial palsy. With specialised training in neurological rehabilitation and a deep understanding of facial neuromuscular retraining, she is recognised as a leading Physiotherapist in Mohali. At The Brigit Clinic, Dr. Aayushi combines evidence-based techniques, such as mirror therapy and EMG biofeedback, with a personalised touch to create effective treatment plans that restore both function and confidence. Her patient-centric approach ensures that every individual receives the dedicated care and support they need throughout their recovery journey, making her the preferred choice for anyone seeking the Best Physiotherapist in Mohali.

 

Book an Appointment today - 
 📞 0172 - 3137922 |  🌐 Read Reviews | 📍 Get Directions
September 24, 2025 / by Manu Mengi
Ankylosing Spondylitis Explained - From Diagnosis to Daily Management - Dr. Manu Mengi

Ankylosing Spondylitis Explained: From Diagnosis to Daily Management

Ankylosing spondylitis affects approximately 1.7 million adults in the United States, with a prevalence rate of 0.2-0.5% of the population. Unlike common backaches that come in short, painful spells, the pain from this chronic inflammatory condition is typically long-lasting and can significantly impact one’s quality of life. Most people develop ankylosing spondylitis during their late teens or early twenties, with about 80% of patients experiencing symptoms before age 30.

When examining genetic factors, more than 95% of Caucasian individuals with ankylosing spondylitis carry the HLA-B27 gene. The condition also shows a gender disparity, occurring twice as frequently in men as in women. While there’s no cure for ankylosing spondylitis, early detection and appropriate treatment can help manage symptoms and potentially slow disease progression. In this comprehensive guide, we’ll explore everything from diagnosis methods like HLA-B27 testing and x-ray findings to various management strategies, including medications, physical therapy, and surgical options for those with advanced spinal changes.

Understanding Ankylosing Spondylitis

Ankylosing spondylitis (AS) belongs to a family of inflammatory diseases known as spondyloarthritis, which primarily affects the spine and sacroiliac joints. This condition is characterised by its autoimmune nature – essentially, your immune system mistakenly attacks your own body instead of protecting it.

What is autoimmune arthritis of the spine?

Ankylosing spondylitis is fundamentally an inflammatory disease of the axial skeleton. Unlike typical wear-and-tear arthritis, AS is driven by chronic inflammation that can eventually lead to new bone formation and fusion of vertebrae. Although experts haven’t pinpointed the exact cause, genetic factors play a crucial role – specifically, mutations in genes like human leukocyte antigen-B (HLA-B27). Research shows that over 90% of white individuals with AS carry this mutated gene.

The condition is generally considered more autoinflammatory than autoimmune, with the innate immune system playing a central role in its development. However, emerging research suggests AS might actually represent a combination of both autoinflammatory and autoimmune processes.

How AS affects the sacroiliac joints and spine

AS typically begins with inflammation in the sacroiliac joints, where your spine connects to your pelvis. These large joints are used whenever you move or shift your hips. The inflammation causes pain and stiffness, particularly noticeable in the lower back. As the disease progresses, this inflammation can spread upward along the spine.

Eventually, in severe cases, the ongoing inflammation triggers the body’s healing response, leading to new bone formation. This process can cause vertebrae to fuse, creating the characteristic “bamboo spine” appearance visible on X-rays. This fusion reduces spine flexibility and may result in a hunched posture.

Beyond the spine, AS can affect other joints such as the shoulders, hips, and knees. Moreover, approximately 25-35% of individuals develop acute anterior uveitis (eye inflammation), and up to 50% experience inflammatory bowel disease.

Difference between AS and non-radiographic axial spondyloarthritis

AS and non-radiographic axial spondyloarthritis (nr-axSpA) represent two ends of the same disease spectrum. The key distinction lies in imaging results – particularly X-rays of the sacroiliac joints.

In AS (also called radiographic axial spondyloarthritis), damage to the sacroiliac joints is clearly visible on X-rays. Conversely, nr-axSpA patients show similar symptoms but without definitive X-ray evidence of sacroiliitis. Nevertheless, MRI technology might reveal active inflammation in nr-axSpA patients even before changes appear on X-rays.

Interestingly, these subtypes show demographic differences. AS affects males more frequently (about 70.4% of cases), whereas nr-axSpA shows a more balanced gender distribution (males account for approximately 46.5%). Furthermore, HLA-B27 prevalence is lower in nr-axSpA patients (54.3%) compared to AS patients (92.7%).

Is your back pain inflammatory? Don't ignore persistent stiffness. Consult with an experienced Back Pain Doctor in Mohali at The Brigit Clinic for an accurate diagnosis. Book Your Appointment Today!

Recognising the Symptoms Early

Early detection of ankylosing spondylitis starts with recognising its distinctive symptoms. The signs often develop gradually over months or years and may fluctuate in intensity.

Inflammatory back pain symptoms to watch for

The hallmark of ankylosing spondylitis is inflammatory back pain, which differs significantly from mechanical back pain. Pain typically begins in early adulthood before age 40 and develops gradually rather than suddenly. Initially, symptoms might come and go for weeks or months at a time.

What makes this pain unique:

  • Worsens after prolonged rest or sitting
  • Improves with physical activity
  • Often most severe in the early morning or during the night
  • Frequently causes stiffness lasting more than an hour after waking

Notably, this pattern reverses what we see in typical back pain, where rest usually provides relief and activity worsens symptoms.

Sacroiliac joint inflammation and stiffness

Sacroiliitis—inflammation of the sacroiliac joints where your spine connects to your pelvis—is frequently the first sign of ankylosing spondylitis. This inflammation causes pain in the lower back and buttock areas that can radiate to the hips, thighs, and sometimes legs.

The pain from sacroiliitis may feel suddenly sharp and stabbing or present as a constant dull ache. Many patients report pain that worsens when turning or rotating their hips. This discomfort can significantly affect daily activities, especially sitting for extended periods.

Fatigue, eye inflammation, and other systemic signs

Beyond joint symptoms, ankylosing spondylitis often affects multiple body systems. Extreme fatigue affects many patients regardless of how much they rest. Additionally, about 25-35% of individuals develop uveitis—inflammation of the eye’s iris—causing redness, pain, blurred vision, and light sensitivity.

Other systemic manifestations may include:

  • Inflammatory bowel disease (affecting up to 50% of individuals)
  • Unexplained weight loss
  • Skin rashes
  • Shortness of breath

Progressive spinal fusion and posture changes

If left untreated, ongoing inflammation triggers the body’s healing response, leading to new bone formation between vertebrae. This process, called spinal fusion, creates the characteristic “bamboo spine” appearance visible on X-rays.

As the disease advances, postural changes become increasingly apparent. The spine may develop increased kyphosis (forward curve), with compensatory changes in the lower body. The progressive fusion limits mobility and can eventually restrict chest expansion, affecting breathing capacity.

Experiencing morning back stiffness or unexplained fatigue? Early intervention is key. Visit the leading Ortho Clinic in Mohali for a comprehensive evaluation. Call us at +91 87250 11661.

Diagnosis and Testing Methods

Diagnosing ankylosing spondylitis often presents significant challenges, as the condition develops slowly with no definitive single test to confirm its presence.

Early detection of ankylosing spondylitis

Obtaining an early diagnosis typically requires a combination of clinical assessment, imaging, and laboratory tests. The modified New York Criteria remains the most commonly used diagnostic framework, requiring both clinical symptoms and radiographic evidence of sacroiliitis. Consequently, many patients experience a delay of 7-10 years between symptom onset and formal diagnosis.

Role of HLA-B27 testing in diagnosis

While approximately 90-95% of ankylosing spondylitis patients test positive for HLA-B27, this genetic marker alone cannot confirm diagnosis. Indeed, only 1-5% of people carrying this gene variant actually develop the condition. The test primarily serves as a supporting factor in diagnosing suspected cases, given that 7.5% of white Americans carry HLA-B27 without developing symptoms.

X-ray findings and radiographic changes

X-rays represent the traditional gold standard for assessing structural changes in ankylosing spondylitis. Key radiographic findings include bilateral sacroiliitis, vertebral “squaring,” syndesmophytes (vertical bony outgrowths), and in advanced cases, the characteristic “bamboo spine” appearance. For reliable assessment of spinal progression, an observation period of at least 2 years is recommended.

MRI and blood tests for inflammation markers

MRI has revolutionised early diagnosis by detecting inflammatory changes before they become visible on X-rays. Blood tests for inflammation—including erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)—often show elevated levels, though these markers may be normal in up to half of patients. Unlike other inflammatory arthritis conditions, ankylosing spondylitis patients sometimes show minimal blood inflammation despite significant symptoms.

Confused by your symptoms and test results? Get a clear diagnosis and personalised treatment plan from the Back Pain Specialist in Mohali. 
Visit Our Google My Business Page to See Patient Reviews

Treatment and Management Options

Treatment options for ankylosing spondylitis have expanded tremendously, offering hope for symptom management and disease control. While there’s no cure, proper treatment can help most patients lead active lives.

NSAIDs for ankylosing spondylitis pain relief

NSAIDs remain the cornerstone first-line treatment for AS. These medications effectively reduce inflammation and pain while improving function. Studies show all NSAIDs significantly outperform placebo in reducing pain severity. Etoricoxib ranks as the most effective NSAID for AS patients. However, these medications carry risks – particularly gastrointestinal issues with diclofenac and naproxen showing significantly higher rates of GI events compared to placebo.

DMARDs and biologics: slowing disease progression

For patients who don’t respond adequately to NSAIDs, disease-modifying treatments offer hope. TNF inhibitors dramatically improve symptoms by blocking the TNF cytokine, a key inflammation driver. Long-term TNF inhibitor use may reduce radiographic progression in AS patients.

Newer biologics include IL-17 inhibitors (secukinumab, ixekizumab, bimekizumab), which effectively target another inflammatory pathway. JAK inhibitors like tofacitinib and upadacitinib, taken orally rather than by injection, represent the latest treatment advance.

Corticosteroid injection for flare-ups

Corticosteroid injections can temporarily relieve inflammation in specific joints. Pain relief typically lasts several months. Side effects may include short-term pain flares, facial flushing, and blood sugar increases. Doctors typically limit injections to three times yearly in the same joint, with at least three months between treatments.

Physical therapy and orthopaedic bracing

Physical therapy stands as a crucial element in AS management. Regular exercises help reduce stiffness, improve posture, decrease pain, strengthen muscles, and enhance flexibility. Physical therapists can design personalised programs incorporating core strengthening, flexibility exercises, and deep breathing techniques.

Orthopaedic bracing provides support and stability for affected joints. Properly fitted braces can reduce pain, improve stability, and enhance function.

Surgical options: hip replacement and spinal osteotomy

When conservative treatments fail, surgical intervention may be necessary. Total hip arthroplasty effectively alleviates pain and improves function in AS patients with severe hip involvement. For significant spinal deformities, osteotomy procedures can correct posture and restore sagittal balance.

Disability reduction and prevention of joint fusion

The ultimate goal of all treatments is to prevent disability and joint fusion. Early intervention with appropriate medications, consistent physical therapy, and lifestyle modifications offers the best chance at maintaining function and quality of life.

Explore advanced Back Pain Treatment in Mohali tailored to your needs. From NSAIDs to modern therapies, find relief at The Brigit Clinic. Explore Your Treatment Options

Conclusion

Ankylosing spondylitis presents unique challenges for both patients and healthcare providers. Though no cure exists currently, early detection coupled with comprehensive treatment significantly improves quality of life. Understanding the distinctive symptoms—particularly inflammatory back pain that improves with activity rather than rest—helps identify this condition before irreversible damage occurs.

After diagnosis, many treatment options become available to manage symptoms effectively. NSAIDs generally serve as first-line therapy, while biologics and JAK inhibitors offer hope for those with inadequate response. Additionally, regular physical therapy plays a crucial role in maintaining spinal mobility and function throughout the disease course.

Living with ankylosing spondylitis certainly requires adjustments, but advances in treatment have transformed the outlook for most patients. The combination of medication, exercise, and lifestyle modifications allows many individuals to lead active, fulfilling lives despite their diagnosis. Most importantly, proactive management helps prevent the most severe complications like spinal fusion and significant disability.

For anyone experiencing persistent lower back pain with morning stiffness, seeking medical evaluation promptly might make all the difference. The journey from diagnosis to daily management may seem daunting at first, but with proper support and treatment, the path forward becomes much clearer. Remember that each person’s experience with ankylosing spondylitis differs, and finding the right treatment approach often requires patience and partnership with healthcare providers.

Key Takeaways

Understanding ankylosing spondylitis is crucial for early detection and effective management of this chronic inflammatory condition that affects millions worldwide.

• Early recognition saves mobility: Inflammatory back pain that worsens with rest but improves with activity signals AS, unlike typical back pain patterns.

• Genetic testing provides clues: Over 90% of AS patients carry the HLA-B27 gene, but only 1-5% of carriers develop the condition.

• Treatment prevents fusion: NSAIDs, biologics, and consistent physical therapy can slow disease progression and prevent irreversible spinal fusion.

• Exercise is medicine: Regular physical therapy and movement are essential for maintaining spinal flexibility and reducing long-term disability.

• Early diagnosis matters: Most patients wait 7-10 years for diagnosis, but prompt treatment significantly improves quality of life outcomes.

The key to successful AS management lies in recognising symptoms early, pursuing comprehensive treatment, and maintaining an active lifestyle. While there’s no cure, modern treatments allow most patients to lead fulfilling lives when properly managed.

FAQs

Q1. What are the early signs of ankylosing spondylitis?

A1. Early signs include persistent lower back pain that improves with activity, morning stiffness lasting over an hour, and pain in the sacroiliac joints. Some people may also experience fatigue, eye inflammation, and other systemic symptoms.

Q2. How is ankylosing spondylitis diagnosed?

A2. Diagnosis involves a combination of clinical assessment, imaging tests (X-rays and MRI), and blood tests. Doctors look for inflammatory back pain symptoms, radiographic evidence of sacroiliitis, and may test for the HLA-B27 gene, which is present in most patients with AS.

Q3. What treatment options are available for ankylosing spondylitis?

A3. Treatment options include NSAIDs for pain relief, biologics like TNF inhibitors to slow disease progression, physical therapy to maintain mobility, and, in some cases, corticosteroid injections or surgery for severe joint damage.

Q4. Can ankylosing spondylitis be cured?

A4. There is no cure for ankylosing spondylitis, but early detection and appropriate treatment can effectively manage symptoms and potentially slow disease progression, allowing many patients to lead active lives.

Q5. How does ankylosing spondylitis differ from typical back pain?

A5. Unlike typical back pain that improves with rest, ankylosing spondylitis pain often worsens with inactivity and improves with exercise. Pain is also typically more persistent, accompanied by morning stiffness, and often starts before age 40.

Ready to take the next step towards managing your AS? Schedule a consultation with the Best Back Pain Doctor in Mohali, Dr. Manu Mengi. Call +91 87250 11661 or visit us at SCO – 41, Sector - 80, Mohali.

About Dr. Manu Mengi – Best Ortho Doctor in Mohali

Dr. Manu Mengi is a renowned and trusted name in orthopedics, dedicated to providing exceptional care for patients with complex joint and spine conditions like Ankylosing Spondylitis. With extensive experience and a patient-centric approach, he is committed to accurately diagnosing the root cause of pain and creating effective, personalised management plans. At The Brigit Clinic, one of the leading Orthopedic Clinics in Mohali, Dr. Mengi utilises the latest advancements in medical science to help patients reduce pain, improve mobility, and enhance their quality of life. His expertise makes him the preferred choice for anyone seeking the Best Ortho Doctor in Mohali.

Book an Appointment today - 
 📱 +91 87250 11661 | 🌐 Read Reviews |📍 Get Directions

 

September 24, 2025 / by Manu Mengi